TIDMALM
RNS Number : 8919O
Allied Minds PLC
15 June 2022
15 June 2022
Allied Minds plc
("Allied Minds" , the "Group", or the "Company")
Annual Results and Notice of AGM
Allied Minds plc (LSE: ALM), the IP commercialisation company
focused on early-stage company development within the technology
sector, announces its annual results for the year ended 31 December
2021.
Investment and Financial Highlights
-- $68.5 million invested in portfolio companies, of which $61.8 million was raised from third-party investment.
-- Cash and cash equivalents at 31 December 2021: $9.7 million (FY20: $24.5 million), of which $9.0 million is held
within Allied Minds (FY20: $22.3 million).
-- Revenues of $1.5 million (2020: $0.5 million) mainly from non-recurring engineering (NRE) and service contracts
within Bridgecomm, reflecting the early stage nature of our portfolio companies.
-- Share buyback programme launched in June 2021 to buy back up to $3.0 million of the Group's shares to
redistribute excess capital for the benefit of shareholders.
o A total of 2,537,712 shares, to date, have been purchased at a
cost of $0.7 million.
Selected Portfolio Company Highlights
-- BridgeComm (consolidated subsidiary):
o Commenced sales of its Optical Inter-Satellite Link terminals
- used in programs for space and ground applications with
commercial and US Government customers.
o Launched Managed Optical Communication Array (MOCA) technology
which allows for multi-domain capabilities to share large volumes
of data significantly faster with increased security.
o Developed a proprietary, patent awarded set of technologies
around point to multipoint optical communications using MOCA
technology.
o Advanced one-to-many optical wireless communications (OWC)
using MOCA technology to support Low Earth Orbit (LEO)
constellations.
o Post year end, Allied Minds and AE Industrial HorizonX Venture
Fund I, LP (HorizonX), jointly contributed an aggregate of $0.8
million of convertible bridge financing to BridgeComm, each
contributing $0.4 million. The bridge financing will be applied to
support the business to the completion of a new financing
round.
-- Federated Wireless (equity accounted investment):
o Awarded multi-million-dollar contract from the US Department
of Defense as part of its 5G Smart Warehouse Initiative.
o In November 2021, Allied Minds invested $4,283,000 in
Federated as bridge financing, which is held at fair value of
$4,500,000 at 31 December 2021.
o Post year end, Federated Wireless announced two Series D
fundraises for a total of $72 million, giving Federated Wireless a
post money valuation of $302 million.
o Allied Minds' bridge financing fully converted following the
post year end completion of the Series D funding rounds. As a
result, Allied Minds' fully -- diluted ownership of the issued
share capital of Federated Wireless stands at 23.96%.
o Key appointments made to the company's leadership team in
2021, including Chief Commercial Officer and Chief Financial
Officer.
o Achieved 3.8x revenue growth in 2021 and expects continued
momentum through 2022 and beyond.
-- OcuTerra (ordinary and preference share holding):
o Closed $35 million Series B funding from new investors and as
part of the raise the company was deconsolidated from the group
financial statements.
o Proceeds will be used to fund a Phase II clinical trial of its
OTT166 asset in diabetic retinopathy, as well as for other working
capital needs.
o The company is preparing for the start of the Phase 2 trial,
and is building out its managerial and clinical team.
o Now funded for the immediate future.
-- Orbital Sidekick (investment held at fair value):
o Closed $16 million Series A funding led by Temasek - included
new investors Energy Innovation Capital and Syndicate 708 and
existing investors Allied Minds and 11.2 Capital.
o Launched most powerful satellite yet, Aurora, to collect and
analyse hyperspectral data, with a broad focus on
sustainability.
o Expanded the team from 12 to 39, which is expected to reach 65
employees by the end of 2022.
o Expanding satellite operations within existing partnerships
with Phillips 66 and iPIPE to provide better leak prevention and
monitoring for the energy sector - full commercialisation
anticipated during 2023.
o Signed a contract with one of the largest pipeline operators
in North America - Energy Transfer - to deliver recurring
monitoring services from our satellites through 2023.
o Orbital has sufficient cash to fund the business until August
2022 and is in advanced talks with potential investment firms and
strategic partner groups to secure the required funding.
-- Touch Bistro (investment held at fair value)
o On 28 March 2022, Allied Minds announced that it had completed
the disposal of its residual shareholding in Touch Bistro for $5.5m
CAD ($4.4m USD) in line with its strategy of monetising its
investment portfolio. Of the sale proceeds, $4.97m CAD has been
received and $0.53m CAD is to be held in escrow, with an initial
release date in Q3 2022, subject to any then outstanding
claims.
Corporate Developments
Post-period end, Allied Minds announced in March 2022 that it
will undertake a formal review of the Company's strategic options
(the "Strategic Review") including, but are not limited to, a sale
of the Company itself, which the Board intends to conduct under the
framework of a "Formal Sale Process" in accordance with Rules 2.4
and 2.6 of the Takeover Code, alternatively, to seek to distribute
certain assets and any cash reserves directly back to shareholders
through a re-structure.
The Company also announced the resignation of Non-Executive
Directors, Mark Lerdal and the forthcoming resignation of Harry
Rein. Harry Rein and Bruce Failing, the Senior Independent
Director, and the Company's largest shareholders are working to
ensure an orderly transition to any new Independent Directors.
In compliance with Listing Rule 9.6.3R, the following document
will be submitted to the National Storage Mechanism and will
shortly be available for inspection at
https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism
:
-- Annual Report and Accounts for the year ended 31 December 2021
Printed copies of these documents will be posted to shareholders
shortly. Copies will also be available shortly on the Investor
Relations section of the Company's website at
http://www.alliedminds.com/investor
The 2022 Annual General Meeting will be held at 2.00 pm EDT on
27 July 2022 at the Company's headquarters located at 374 Congress
Street, Suite 308, Boston, Massachusetts 02210, USA.
For further information, please contact:
Allied Minds plc c/o Instinctif Partners
Bruce Failing
Instinctif Partners (Communications)
Tim Linacre / Rozi Morris / Joe Quinlan alliedminds@instinctif.com
About Allied Minds
Allied Minds plc is an IP commercialisation company focused on
early stage company development within the technology sector. With
origination relationships that span US federal laboratories,
universities, and leading US corporations, Allied Minds
historically created, and now operates and funds, a portfolio of
companies to generate long-term value for its investors and
stakeholders. Based in Boston, Allied Minds supports its businesses
with capital, management, expertise and shared services. For more
information, please visit www.alliedminds.com .
Forward looking statements
This Annual Results Release and the 2021 Annual Report contain
statements that are or may be forward-looking statements, including
statements that relate to the Company's future prospects,
developments and strategies. The Group considers any statements
that are not historical facts as "forward-looking statements". The
forward-looking statements are based on current expectations and
are subject to known and unknown risks and uncertainties that could
cause actual results, performance and achievements to differ
materially from current expectations, including, but not limited
to, those risks and uncertainties described in the risk management
section of the 2021 Annual Report. These forward-looking statements
are made in good faith based on assumptions regarding the present
and future business strategies of the Company and the environment
in which it will operate in the future and such statements should
be treated with caution due to the inherent uncertainties,
including both economic and business risk factors, underlying any
such forward-looking information. Each forward-looking statement
speaks only as at the date of this Annual Results Release. Except
as required by law, regulatory requirement, the Listing Rules and
the Disclosure Guidance and Transparency Rules, neither the Company
nor any other party intends to update or revise these
forward-looking statements, whether as a result of new information,
future events or otherwise.
2021 Annual Report and Accounts
STRATEGIC REPORT
Chairman's Report
This is my last Chairman's letter to you having taken the
decision to stand down from the Board upon signing off these
accounts.
Following this decision and conscious of the recent board
changes, there is a need to appoint additional directors to the
board of the Company. The Directors are working closely with the
Company's largest shareholders to identify and recruit new
directors to the board of the Company.
Allied Minds has an unusual Board structure, having been
comprised solely of Non-Executive Directors, with each portfolio
company having its own Board of Directors. The Non-Executive
Directors of Allied Minds serve on the Boards or have observer
status on each active portfolio company. This has enabled us to
work in a cost-efficient manner while utilising the skills of the
Allied Minds directors.
Over my time as Chairman I, and my Board colleagues, have
reviewed the portfolio of investments we inherited and took the
appropriate tough decisions to ensure we maximise those investments
with the most perceived value and move them towards
monetisation.
As at the start of 2021, all the portfolio companies Allied
Minds was invested in were essentially pre or at the early stages
of generating revenue, and a number of them faced substantial
challenges. These challenges resulted in us exiting or closing our
investments in several companies, leaving us with six companies
which, in my and the Board's view, have significant potential and
merit support.
This restructuring of the portfolio has been challenging. In
several cases hopes and expectations of the value of our
investments were out of line with reality and this has had a
consequential impact on the share price. However, this rebasing of
the value of the investments, and providing clarity to all
shareholders, needed to take place, and we now have six investments
which have potential. Of these our investment in Federated Wireless
is the most valuable, as demonstrated by the recent Series D
upround at a post-money valuation of $302 million.
As part of the Board's review of its strategic options, and its
frustrations with the undervaluation of the Company on the stock
market, and the costs of being a listed entity, the Board announced
in March 2022 that we were undertaking a formal strategic review
and sale process. This review may lead to an offer for the Company,
or a distribution of assets and cash to shareholders.
It has been my pleasure to serve as your Chairman, and I wish my
successor every success.
Harry Rein
Chairman
14 June 2022
Company Overview
Overview
Allied Minds is an IP commercialisation company primarily
focused on early-stage company development within the technology
sector.
We have historically invested in companies at an early stage,
including seed investments to build companies based on a technical
breakthrough or invention. As such, our investments have
significant upside potential, but also carry significant risk
inherent in the early-stage model.
The Group is currently comprised of six portfolio companies
based upon a broad range of underlying innovative technologies
ranging from wireless connectivity to space-based imagery and
analytics.
The Group remains focused to execute its plan to maximise the
value of its portfolio company interests and deliver well-timed,
risk-adjusted returns for its shareholders.
Model
As a manager of a technology-focused portfolio in which we hold
significant ownership positions, we seek to provide hands-on
support over the life of our companies to support their growth,
focusing on enabling and driving commercialisation, supporting
follow-on investment rounds, and positioning for superior
monetisation opportunities.
We seek to play an active role in developing the strategic
direction of our portfolio companies and driving ongoing planning
and assessment. Our Non-Executive Directors serve on the boards of
directors of our portfolio companies, working with them to develop
and implement strategic, operating and funding plans. We evaluate
on an on-going basis the progress and potential of each of the
portfolio company's businesses and make strategic and funding
decisions based on the regular review of operational and financial
performance and the achievement of key milestones. Together with
our management, the respective portfolio company boards of
directors define the critical milestones, or inflection points, for
each portfolio company and measure tangible progress towards
commercialisation and the key factors for a successful monetisation
event.
Where appropriate, we seek to include partners who validate the
market opportunity and can provide support and/or commercial
commitments to accelerate, expand and/or de-risk the path to
commercialisation. Co-investors in later rounds include financial,
strategic and commercial partners.
Strategy
Allied Minds is focused on supporting its existing portfolio
companies and maximising monetisation opportunities for portfolio
company interests. For some time, the Board has been reviewing the
range of strategic options available to it in order to return value
to shareholders. The Board resolved, in March 2022, to undertake a
formal review of the Company's strategic options (the "Strategic
Review") including, but not limited to, a sale of the Company
itself, which the Board intends to conduct under the framework of a
"Formal Sale Process" in accordance with Rules 2.4 and 2.6 of the
Takeover Code, alternatively, to seek to distribute certain assets
and any cash reserves directly back to shareholders through a
re-structure. The Strategic Review is solely aimed at creating
and/or realising shareholder value.
Subject to conclusion of the Strategic Review, the Board will
continue to aim to monetise the Group's ownership positions at the
appropriate time, recognising the value and benefit in achieving
well-timed risk-adjusted returns for the benefit of shareholders.
Upon the event of successful monetisation events from the sale of
portfolio companies or portfolio company interests, Allied Minds
anticipates distributing the net proceeds to its shareholders,
after due consideration of potential follow-on investment
opportunities within the existing portfolio and working capital
requirements.
The value of Allied Minds is dependent upon the value of our
existing portfolio companies and our ability to translate that
value into cash as effectively and efficiently as possible and to
deliver that cash, net of our obligations and operating cash needs,
to our shareholders.
The Board aims to ensure that the Group is being managed in as
cost efficient manner as possible, regularly reviewing the on going
costs associated with being a listed company. The Board notes that
the costs of maintaining a premium listing on the London Stock
Exchange are prohibitive for a company of Allied Minds' current
size and maintaining a public listing is expensive with more than
50 per cent of the Company's annual budget devoted to meeting the
requirements of being a listed company.
Outlook
There was substantial technical and commercial progress from
within some portfolio companies during 2021 and post period,
including successful funding rounds, development milestones,
contract wins and industry partnerships. The milestones achieved
demonstrate examples of solving difficult technical problems,
developing innovative products and services across a range of large
potential markets, establishing important partnerships to develop
technology and go to market channels, and the creation of
shareholder value.
The Board of Allied Minds continually assesses its portfolio of
investments and with a member of the Board sitting on or leading
the boards of all our material investments, the Board can ensure it
is optimally placed to take timely decisions based on up to date
information. This will not be impacted by the departure of Harry
Rein as Chairman and a process is currently underway to ensure the
appropriate number of non-executive directors serve on the
board.
This approach has ensured that decisive actions are taken, even
if these are sometimes difficult such as the decision to liquidate
Spin Memory, and sell Spark Insights.
Although the remaining portfolio companies are mostly at a
relatively early stage in their lifecycle, the Board is positive
about their prospects upon exit if the portfolio companies continue
to meet their planned technical and commercial goals.
Portfolio Company Valuation
Of the Company's six active portfolio companies, one is
currently majority owned and controlled, and therefore fully
consolidated in the Company's consolidated financial statements
prepared in accordance with UK adopted International Accounting
Standards.
Of the remaining five portfolio companies, the Company holds a
significant minority stake in three of these companies and small
positions in both TouchBistro, Inc. (as a result of the
stock-for-stock sale of TableUp, Inc.) and Concirrus (as a result
of the stock-for-stock sale of Spark Insights, Inc.). In each case,
where Allied Minds holds a significant minority stake, it is able
to exercise significant influence over the portfolio company by
virtue of its large, albeit minority, ownership stake in the
portfolio company and its representation on the board of directors.
The investment in preferred stock in these portfolio companies is
accounted for under IFRS 9 and is classified by the Company as an
investment at fair value in the Company's consolidated financial
statements. Due to the equity-like characteristics of the Company's
common stockholdings in Federated Wireless, this investment is
accounted for under IAS 28 and is classified by the Company as
investments in associates. Accordingly, since Allied Minds has
significant influence over this entity through the voting
rights/potential voting rights held, it gives access to the returns
associated with an ownership interest in this associate. For
Ordinary stock holdings, where the group does not have significant
influence, these investments are held at fair value in the
Company's consolidated financial statements.
Allied Minds provides qualitative and quantitative disclosure in
relation to the commercial and financial progress of its portfolio
companies, and directional commentary on valuation. In addition,
where commercially possible, Allied Minds provides, for each
portfolio company: (i) the date of the last equity funding round,
(ii) the post-money valuation of such round, (iii) the named key
co-investors in such round, and (iv) the Company's issued and
outstanding ownership, and fully-diluted ownership, of such
portfolio company.
This information is set forth in the Portfolio Review and
Developments section below. The ownership interests are as of 03
May 2022. The fully-diluted percentages take into account
outstanding stock options granted to employees, directors and
advisors, current stock options available for grant pursuant to the
company's stock option plan, and outstanding warrants to purchase
common and preferred stock.
The post-money valuations disclosed for each entity below do not
represent IFRS 13 fair values but rather, are based on the
pre-money valuation set by the investors in the latest financing
round plus the total money raised in that round.
There can be no guarantee that the aforementioned post-money
valuations of the portfolio companies will be considered to be
correct in light of the future performance of the various
companies, or that the Company would be able to realise proceeds in
the amount of such valuations, or at all, in the event of a sale by
it of any of its portfolio companies or its ownership interest in
such portfolio companies.
Portfolio Review and Developments
----------
1) BridgeComm Inc. (BridgeComm) (consolidated subsidiary)
BridgeComm is developing high-speed optical wireless
communications to provide fast, secure, enterprise-grade broadband
service for space, terrestrial and 5G connectivity. Interest in the
optical communications market is growing with commercial space
opportunities and government programs looking for the unique
characteristics of high speed and security.
BridgeComm has developed a proprietary, patent awarded set of
technologies around point to multipoint optical communications
using Managed Optical Communication Array (MOCA) technology. This
means BrideComm can truly complement legacy Radio Frequency (RF)
technology. BrideComm has demonstrated this capability to customers
and is now developing terminals for specific applications. Key
partners include Space Micro for production of point to multipoint
terminals based on MOCA technology and Boeing that has supported
BridgeComm and partnered on key applications.
The conflict in the Ukraine has highlighted the value of
Bridgecomm's point to multi point technology. BridgeComm's
one-to-many high-speed optical communications technology allows for
dispersed communications which are difficult to detect and/or
intercept. Current battlefield communications tend to use a single
point of distribution with the risk of a single point of failure.
BridgeComm's one-to-many communications enables a mesh network,
eliminating this point of failure. The goal is to install 1000's of
satellites with BridgeComm's non mechanical software driven optical
communications system. This would allow dispersed battlefield
control from space. In addition it is hoped that BridgeComm's
technology will provide the optical intersatellite communications
capability of choice for all proliferated low earth orbit
constellations.
BridgeComm will require up to $5mm additional capital to deliver
an existing contract with The Space Development Agency, the
objective of which is to prove MOCA technology over longer
distances.
BridgeComm is currently in partnering discussions with
Aeroequity Industrial partners to provide additional funding and US
government sourcing expertise. In addition, for BridgeComm to
succeed as a US government vendor, it will need to be a US based
company. Because AEI brings technical and government knowledge, it
is planed that Allied Minds will be a large minority shareholder
post transaction which is expected to be a down round to the last
valuation.
Holdings and valuation:
-- Date of Last Funding Round: September 2018
-- Post-Money Valuation: $38.0 million
-- Co-Investors: Boeing HorizonX Ventures (venture arm of Boeing Company)
-- Allied Minds' Issued and Outstanding Ownership: 81.15%
-- Allied Minds' Fully-Diluted Ownership: 62.92%
2) Federated Wireless Inc. (Federated) ( equity accounted investment)
Founded in 2012, Federated is the market leader in Citizen Band
Radio Service (CBRS) shared spectrum. Shared spectrum, also known
as CBRS , is an innovative technology that delivers the best
attributes of traditional wireless and Wi-Fi, with lower fixed
cost, higher quality, and greater efficiency and scale.
As the first to market with a Spectrum Access System ("SAS"),
Federated Wireless is the nationwide leader in enabling,
commercializing, and driving adoption of shared spectrum. With more
than 350 customers and over 90,000 connected devices across the
United States and territories, the company serves a customer base
spanning defense, government, manufacturing, telecommunications,
utilities, real estate, and education, with a wide range of use
cases ranging from network densification and mobile offload to
private wireless and industrial IoT. Noteworthy customers include
Charter, Comcast, Verizon, the US Department of Defense and
Carnegie Mellon University.
The company has driven several significant advancements in 2021.
These include the launch of the secondary CBRS spectrum market via
its Spectrum Exchange; significant deployments of a dedicated CBRS
network for IoT research at Fort Carson, CO, and another for
modernization of the Marine Corps Logistics Command warehouse
operations in Albany, GA; along with deployment of the first CBRS
networks in Puerto Rico and the U.S Virgin Islands, delivering
service to the region's Wireless Internet Service Providers (WISPs)
and Mobile Network Operators (MNOs). The last year has seen its
customer and partner base expand rapidly into new verticals and the
number of active CBRS devices grow significantly. As of the
publication of this report, the company has more than 350
customers, with more than 90,000 devices deployed, which together
indicate strong momentum for the entire market segment.
Accelerating private 5G wireless for enterprise
Federated Wireless is powering innovation in how networks are
delivered and reshaping wireless connectivity for cloud-enabled
technologies. The company is focused on accelerating enterprise
adoption of private wireless networking and delivering new
capabilities for network edge innovation. Its goal is to simplify
and automate how wireless networks are purchased, deployed,
provisioned, and managed, making it easier for organizations to
customize their network to business requirements, and speed time to
market with advancements in IoT, VR/AR, and other digital
technologies.
Critical to the Federated Wireless strategy is expanding its
edge solutions, which it will achieve through collaboration with
hyperscale providers that have been growing and strengthening over
the past two years, including AWS, Intel, HPE-Aruba, JMA, Cisco,
and others. The company's top priorities include:
-- Investing in cloud-native tools to empower edge innovation,
including automation, application analytics, and zero touch
provisioning (ZTP);
-- Mobilizing the ecosystem with a heightened focus on
relationship management, business development, and sales
enablement;
-- Expanding product capabilities for sharing in 6 Ghz and
promoting its adoption domestically and internationally; and,
-- Ramping up commercial capacity with increased investment in
Sales, Marketing, and Customer Success.
Investing in growth
In addition to significant investments in product development,
Federated Wireless made key appointments to the company's
leadership team in 2021, including:
-- Industry veteran Chris Swan joined as Chief Commercial
Officer to focus on delivering the very significant growth
opportunity for the business with leadership over sales, marketing,
and customer care.
-- Strategic operations and finance executive Loren Buck joins as Chief Financial Officer.
Financially, Federated Wireless saw 3.8x revenue growth in 2021
and expects continued momentum through 2022 and beyond.
Subsequent to year end, Federated Wireless raised $72 million
through a two stage Series D funding to fuel growth in 5G private
wireless and other strategic focuses. An affiliate of Cerberus
Capital Management, L.P. led the round, with affiliates of Fortress
Investment Group, Giantleap Capital, and LightShed Ventures added
as new investors with existing investors Allied Minds and GIC,
Singapore's sovereign wealth fund, also participating.
Holdings and valuation:
-- Date of Last Funding Round: May 2022
-- Post-Money Valuation: $302 million
-- Co-Investors: Cerberus Capital Management LLP and GIC (Singapore's sovereign wealth fund)
-- Allied Minds' Fully-Diluted Ownership: 23.96%
3) OcuTerra Therapeutics, Inc. (ordinary and preference share holding)
OcuTerra is a clinical stage ophthalmology company developing
innovative small molecule drugs for non-invasive use in treating
ophthalmologic diseases that are currently treated in the early
stages with a "watch and wait" protocol. The company has announced
a Series B financing of $35m that will be used to fund a Phase 2
trial starting in Q3 2022 of its non-invasive eyedrops (OTT166) for
use in early active management of Diabetic Retinopathy. It will be
studied in the trial for the treatment of moderate to severe
non-proliferative and mild proliferative Diabetic Retinopathy.
Diabetic Retinopathy is a disease that results in loss of vision
for diabetic patients.
Phase 1b clinical trials of OTT166 eye drops in patients with
diabetic retinopathy and wet AMD have demonstrated safety,
tolerability and clear clinical evidence of biological activity.
OTT166 is a novel small molecule selective integrin inhibitor that
has been engineered to have the required physiochemical
characteristics to be able to reach the retina , where the damage
occurs, from eye drop application. The current standard of care
involves injections into the eye and/or laser treatment. The
OcuTerra drops are intended to be used earlier in the treatment of
Retinopathy, potentially delaying or eliminating the need for
intravitreal injections. If the Phase 2 trial is successful, the
next step would be a Phase 3 trial involving more patients and if
successful in meeting the clinical end points application to the
FDA for approval.
The company believes that it is well positioned to transform the
treatment of Diabetic Retinopathy. Currently the company is
preparing for the start of the Phase 2 trial, and is building out
its managerial and clinical team.
Allied Minds is a minority shareholder in OcuTerra and as such
there is no current intention to invest any further capital in the
company.
Holdings and valuation:
-- Date of Last Funding Round: November 2021
-- Valuation: $51.3 million
-- Co-Investors: Various third parties
-- Allied Minds' Issued and Outstanding Ownership: 17.06%
-- Allied Minds' Fully-Diluted Ownership: 12.33%
4) Orbital Sidekick Inc. (Orbital) (investment held at fair value)
Orbital has developed a proprietary analytics platform based
upon its hyperspectral technology that allows it to take a
proprietary "chemical fingerprint" from space. Initially, Orbital
is addressing the very current and large concerns about the
environment by focusing on potential energy pipeline failures. By
employing its space-based technology, it is able to detect and
identify natural gas, oil leaks and other failures much more
rapidly than current monitoring techniques in a more cost effective
way and the added benefit of helping to minimise environmental
damage.
Orbital SideKick has grown significantly over the past 12
months, expanding the team from 12 to 39. The Company is expected
to reach 65 employees by the end of 2022. Orbital has invested
heavily in product development, engineering, and analytics, and is
now growing the Sales & Marketing Team ahead of the launch and
commissioning of 6 satellite GHOSt constellation beginning in Q3 of
2022. The Company's technology demonstration mission - Aurora -
successfully validated its hyperspectral sensor technology
performance in a space environment and served as a dress rehearsal
for the GHOSt constellation. The company has recently signed a
contract with one of the largest pipeline operators in North
America - Energy Transfer - to deliver recurring monitoring
services from its satellites through 2023. The Company recently
signed a significant work program contract with In-Q-Tel, and
expects to expand its footprint within the defense &
intelligence community in 2022 and beyond. The Company is also
developing products for the mining and agriculture industries,
along with fire fuel and carbon mapping capabilities.
Orbital has sufficient cash to fund the business until August
2022. Orbital is in advanced talks with potential investment firms
and strategic partner groups to secure the required funding. The
additional funding will allow the company to add its product to an
additional six satellite launches.
Holdings and valuation:
-- Date of Last Funding Round: April 2021
-- Post-Money Valuation: $46 million
-- Co-Investors: Temasek, Energy Innovation Capital and 11.2 Capital
-- Allied Minds' Issued and Outstanding Ownership in respect of preference shares: 26.52%
-- Allied Minds' Fully-Diluted Ownership: 24.11%
5) Concirrus (acquirer of Spark Insights Inc.) (common shares in Concirrus)
On 1 November 2021, Allied Minds announced the disposal of
portfolio company Spark Insights, Inc. to Concirrus, a private
UK-based insurance technology company. The disposal is valued at
$700,000 USD and was paid in Concirrus stock.
6) TouchBistro, Inc. (acquirer of TableUp, Inc.) (common shares in TouchBistro)
On 28th March 2022, Allied Minds announces that it had completed
the disposal of its residual shareholding in Touch Bistro for $5.5m
CAD ($4.4m USD) in line with its strategy of monetising its
investment portfolio. Of the sale proceeds, $4.97m CAD has been
received and $0.53m CAD is to be held in escrow, with an initial
release date in Q3 2022, subject to any then outstanding
claims.
Key Performance Indicators
In 2020, the Company measured its performance through the
percentage level of achievement of management by objectives (MBOs).
These objectives sought to link financial, operational, technical
and other performance milestones established by the Board directly
to remuneration and KPIs. In 2021, however, MBOs were removed
following changes in the Company's management structure and the
absence of Executive Directors.
The following Key Performance Indicators (KPIs) were selected to
measure the performance of the Company in 2021. These objectives
seek to link financial, operational, technical and other
performance milestones established by the Board directly to
remuneration and KPIs, as further set out in the director
compensation schemes previously disclosed to the market.
1. Increase Company Non-Executive Director (NED) engagement at
each portfolio company. We have continued to hold NED roles on the
board of each of the significant portfolio investments.
2. Provide strategic, operational and financing support and
assistance to the portfolio companies through representation on the
board of each portfolio company. We have continued to provide this
support to each of the portfolio companies throughout the
period.
3. Critically evaluate and monitor portfolio company progress
with objective of maximising shareholder return on investment
(ROI). We have critically evaluated the performance and this has
resulted in the investment portfolio changes in the period.
4. Manage HQ cash and expenses to maximise shareholder ROI, HQ
expenses in the current year were $5.69m (2020: $7.11m).
We note that as a result of the strategic changes announced by
the Board on 15 January 2021, the portfolio shall be managed by the
Board, all of whom are Non-Executive Directors, on a go-forward
basis. The Board places equal importance on each of the listed
KPIs.
Financial Review
During 2021, $68.5 million was invested into existing portfolio
companies. This included $6.8 million invested by Allied Minds,
with $61.7 million coming from third-party investment, to further
accelerate the development of the Group's existing companies.
Consolidated Statement of Comprehensive Loss
For the years ended 31 December 2021 2020
$ '000 $ '000
--------- -------------
Revenue 1,544 480
Cost of revenue (443) (210)
Selling, general and administrative expenses (10,569) (10,497)
Research and development expenses (2,650) (4,712)
Finance cost, net (2,788) (1,786)
Other expense (1,338) (38,779)
Other comprehensive loss (41) (116)
--------- -------------
Total comprehensive loss (16,285) (55,620)
of which attributable to:
Equity holders of the parent (15,575) (53,141)
Non-controlling interests (710) (2,479)
Revenue increased by $1.0 million, to $1.5 million in 2021
(2020: $0.5 million). This increase is primarily attributable to
revenue from existing and new contracts in 2021 at BridgeComm. Cost
of revenue at $0.4 million (2020: $0.2 million) was lower as a
percentage of revenue, when compared to the prior year, mainly due
to the nature of the revenue being delivered.
Selling, general and administrative (SG&A) expenses
increased by $0.1 million, to $10.6 million (2020: $10.5 million).
This increase was mainly due to additional professional fees
incurred in regards to the latest financing at OcuTerra
Therapeutics in the first half of 2021.
Research and development (R&D) expenses decreased by $2.1
million, to $2.6 million (2020: $4.7 million). The decrease was
primarily due to the deconsolidation of two subsidiaries in 2021.
The remainder of the decrease reflects the net effect from R&D
spend at the remaining subsidiaries.
Net finance cost increased by $1.0 million in 2021 to $2.8
million (2020: $1.8 million). The increase in the net cost reflects
the impact from the deconsolidation of OcuTerra in the first half
of 2021 of $7.7 million and $0.1 million increase of a convertible
note payable due to the fair value adjustment. This increase was
offset by the $5.2 million decrease of the subsidiary preferred
shares liability balance at BridgeComm as a result of IFRS 13 fair
value accounting. Lastly, interest expense, net of interest income,
was $0.2 million in 2021 (2020: $23 thousand).
Other expenses decreased to $1.3 million (2020: $38.8 million)
reflecting $14.2 million of gain on deconsolidation of OcuTerra and
Spark Insights, $0.4 million of gain from Paycheck Protection
Program (PPP) loan forgiveness and $0.3 million of compensation
from third parties for disposal of fixed assets, offset by $13.9
million loss on investments held at fair value as well as the
company's share of loss of $2.3 million from its associates.
As a result of these factors, total comprehensive loss decreased
by $39.3 million to $16.3 million (2020: $55.6 million). Total
comprehensive loss attributed to the equity holders of the Group
was $15.6 million (2020: loss of $53.1 million) and $0.7 million
loss (2020: $2.5 million) was attributable to the owners of
non-controlling interests.
Consolidated Statement of Financial Position
As of 31 December 2021 2020
$ '000 $ '000
Non-current assets 35,229 44,416
Current assets 20,672 32,584
Total assets 55,901 77,000
Non-current liabilities 213 2,246
Current liabilities 11,033 16,468
Equity 44,655 58,286
Total liabilities and equity 55,901 77,000
Significant performance-impacting events and business
developments reflected in the Company's financial position at year
end include:
Non-current assets
Property and equipment decreased by $ 0.8 million to $0.8
million (2020: $ 1.6 million ), reflecting depreciation expense of
$ 0.5 million, impairment loss of $0.5 million offset by $0.2
million in gain on disposal of fixed assets.
Investments at fair value decreased to $33.9 million (FY20: 41.6
million). The change reflects the recognition of a $5.7 million
investment as a result of the deconsolidation of OcuTerra and $0.7
million investment as a result of the disposal of Spark Insights.
The increase was offset, in part, by a loss of $14.1 million of the
fair value accounting for other investments held at fair value.
Right-of-use assets decreased to $0.4 million (2020: $0.6
million) primarily related to depreciation of $0.3 million offset
by recognition of a new lease entered into by BridgeComm of $0.1
million in 2021.
Current assets
Cash and cash equivalents decreased by $14.8 million to $9.7
million (2020: $24.5 million). The decrease is mainly attributed to
$9.1 million of net cash used in operations, $18.7 million cash
used in investing activities, offset by $13.0 million cash provided
by financing activities.
Trade and other receivables decreased by $0.1 million to $5.9
million (2020: $5.8 million) due to a cumulative decrease in trade
receivables and prepaid expenses of $0.1 million as a result of
deconsolidation of OcuTerra in the first half of 2021.
Other financial assets have increased by $2.8 million to $5.1
million (FY2020: $2.3 million) primarily due to the conversion of
Orbital's convertible note of $1.5 million into preferred shares
upon the closing of the Series A funding offset by Allied Minds'
$4.3 million investment in Federated Wireless in the form of SAFEs
(simple agreements for equity).
Current liabilities
Subsidiary preferred shares decreased by $ 5.2 million to $ 1.3
million (2020: $ 6.5 million) primarily driven by $5.2 million in
IFRS 9 fair value adjustment at BridgeComm for the year.
Deferred revenue increased by $1.3 million to $4.9 million
(2020: $3.6 million) primarily due to new revenue contracts
recognised at BridgeComm in 2021 .
Loans decreased by $0.1 million (2020: $3.1 million) primarily
due to forgiveness of PPP loans.
Non-current liabilities
Lease liabilities decreased by $1.0 million to $0.8 million
(2020: $1.8 million) primarily due to lease payments offset by
issuance of a new lease at BridgeComm in second half of 2021.
Other non-current liabilities decreased by $1.4 million (2020:
$1.4 million) primarily due to loan payments of convertible
promissory notes at OcuTerra Therapeutics.
Equity
Net equity decreased by $13.6 million to $44.7 million (2020:
$58.3 million) reflecting the combination of comprehensive loss for
the period of $16.3 million, repurchase of ordinary shares of $0.7
million offset by the effect of deconsolidation of OcuTerra and
Spark Insights of $3.2 million and $0.2 million charge due to
equity-settled share based payments .
Consolidated Statement of Cash Flows
For the years ended 31 December 2021 2020
$ '000 $ '000
--------- ---------
Net cash outflow from operating activities (9,060) (17,057)
Net cash outflow from investing activities (18,749) (11,341)
Net cash inflow/(outflow) from financing
activities 13,030 (37,684)
Net decrease in cash and cash equivalents (14,779) (66,082)
Cash and cash equivalents in the beginning
of the year 24,489 90,571
--------- ---------
Cash and cash equivalents at the end of
the year 9,710 24,489
The Group's net cash outflow from operating activities of $9.1
million in 2021 (2020: $17.1 million) was primarily due to the
losses for the year of $16.3 million offset by the net effect from
movement in working capital of $1.7 million, other finance charges
of $2.6 million, the adjustment for non-cash items such as
depreciation, amortisation, impairments, share of net loss of
associate, gain on deconsolidation, loss on investments held at
fair value and share-based payment expenses of $2.9 million.
The Group had a net cash outflow from investing activities of
$18.7 million in 2021 (2020: $11.3 million). This outflow was
predominately related to the deconsolidation of OcuTerra and Spark
Insights totaling $13.3 million, the $0.9 million investment made
in the Orbital Series A funding and $4.3 million investment made in
Federated in the form of a SAFE.
The Group's net cash inflow provided by financing activities of
$13.0 million in 2021 (FY20: $37.7 million) reflects, in part,
proceeds from issuance of preferred shares in subsidiaries of $14.6
million and the receipt of $0.2 million of PPP loans. The increase
was offset by $1.1 million in lease payments and $0.7 million
payments to repurchase the company's own shares.
The Group's strategy is to maintain healthy, highly liquid cash
balances that cover its operating expenses as a publicly listed
entity and are readily available for small, follow-on investments
in portfolio companies in a manner consistent with the Board's
strategy for the Company and Group. To further minimise its
exposure to risks the Group does not maintain any material
borrowings or cash balances in foreign currency.
The Directors have further considered the on-going viability of
the Company for the next three years, as required pursuant to the
2018 version of the UK Corporate Governance Code, in the Management
and Governance section of the Annual Report and Accounts at pages
26 to 27.
Risk Management
The execution of the Group's strategy is subject to a number of
risks and uncertainties. The Board has adopted a system of
continuous review in which it regularly consults with management to
identify principal and emerging risks facing the Group and to
assess and determine how to address and mitigate against such risks
in a manner consistent with the Company's risk appetite to achieve
its strategic goals. Throughout the year, the Board considers and
reviews both risks arising from the internal operations of the
Group, and those arising from the business environment in which it
operates. It is possible that one or more of these identified risks
could impact the Group in a similar timeframe which may compound
their effects.
With our focus on early stage company development,
commercialisation and monetisation, the Group inherently faces
significant risks and challenges. The overall aim of the risk
management policy is to achieve an effective balance of risk and
reward, although ultimately, no strategy can provide an absolute
assurance against loss.
The Board has carried out a robust assessment of the principal
and emerging risks facing the Group, including those that would
threaten its business model, future performance, solvency and/or
liquidity. The major risks and uncertainties identified by the
Board are set out below, along with the consequences and mitigation
strategy of each risk.
1. The science and technology being developed or commercialised
by the Group's businesses may fail and/or the Group's businesses
may not be able to develop their innovations and intellectual
property into commercially viable products or technologies. There
is also a risk that some of the portfolio companies may fail or not
succeed as anticipated, whether as a result of technical, product,
market, fund-raising or other risks, resulting in an impairment of
the Group's value.
Impact : The failure of any of the Group's portfolio companies
would impact the Group's value. A failure of one of the major
portfolio companies could also impact the Group's reputation as a
builder of high value businesses and possibly make additional fund
raising at the Group or portfolio company level more difficult.
Mitigation :
-- Before making any follow-on investment in the current
portfolio, extensive due diligence is carried out by the Group
which covers all the major business risks including market size,
strategy, adoption and intellectual property. Where appropriate, we
seek validation through co-investment by other strategic and/or
financial parties.
-- A disciplined approach to capital allocation is pursued
whereby we closely monitor milestone developments before committing
additional capital. Should a project fail to achieve sufficient
progress or is unable to attract other co-investors, we may
terminate the investment.
-- Dedicated leadership with deep industry or sector knowledge,
and relevant technical and/or leadership experience, is recruited
to management positions, and the Group ensures that each portfolio
company has independent directors and/or other advisors, as
appropriate for the relevant stage of development.
-- Each portfolio company holds board of director meetings at
least quarterly, with participation from the Group's Directors,
management and/or investment team, along with senior management and
independent directors and/or advisors, as appropriate, of such
portfolio company.
-- Within the Group there is meaningful operating and investment
expertise that provide direct, hands-on and strategic, operating
and fund-raising support to its portfolio companies, as
appropriate.
-- The Group actively uses third party advisors and consultants,
specific to the particular domain in which a portfolio company
operates, to assist on market strategy and direction.
2. The portfolio companies expect to incur substantial
expenditure in further research and development, product
development, sales and marketing and other operational activities
of its businesses. There is no guarantee that the Group or any of
its individual portfolio companies will become profitable prior to
the achievement of a portfolio company sale or other liquidity
event, and, even if the Group or any of its individual portfolio
companies does become profitable, such profitability may not be
sustainable. The Group may not be able to attract other
co-investors, or monetise its ownership interests in portfolio
companies, during any specific time frame or otherwise on desirable
terms, if at all.
Impact : Allied Minds' objective is to generate returns for its
shareholders through early stage company development within the
technology sector. Such value is expected to be delivered through
the commercialisation and monetisation of these businesses via a
sale or other liquidity event for each. The timing and size of
these potential inflows is uncertain and, should liquidity events
not be forthcoming, or in the event that they are achieved at
values significantly less than the amount of capital invested, then
it would be difficult to sustain the current levels of investment
in the other portfolio companies. This would lead to reduced
participation in funding rounds, which will result in a lower
ownership position, or potentially impact the ability of a company
to raise additional funds.
Mitigation :
-- The Group retains sufficient cash balances in order to
support its cash flow requirements, including Allied Minds'
investment requirements for each portfolio company and for
corporate resources.
-- The Group has close relationships with a wide group of
investors, including within its current shareholder base, and
continues to identify and develop strategic and financial
relationships for co-investing in the Group's portfolio
companies.
-- Non-Executive Directors seek to build and maintain strategic
and financial relationships for the Group, and each portfolio
company continually seeks to engage in strategic and financial
relationships relevant to their respective markets and to maintain
current information on, and awareness of, potential fund-raising
and monetisation strategies.
3. A significant portion of the Group's intellectual property
relates to technologies which originated in the course of research
conducted in, and initially funded by, US universities or other
federally-funded research institutions. Although the Group has been
granted exclusive licenses to use this intellectual property, there
are certain limitations inherent in these licenses, for example as
required by the Bayh-Dole Act of 1980.
Impact : There are certain circumstances where the US government
has rights to utilise the underlying intellectual property without
any economic benefit flowing back to the Group. In the event that
this were to happen, this could impact the financial return to the
Group on its investment in the applicable portfolio companies.
Mitigation :
-- To the Board's knowledge, while these so called "march in"
rights exist, the US government has never had cause to use
them.
-- The Group seeks to develop dual use capabilities for the
technology it licenses and generally tends to avoid use cases
directly applicable to government use.
-- This risk is also mitigated through employing experienced
technology transfer experts supported by our legal team to assess
risks that may arise out of this eventuality.
4. Certain of the portfolio companies currently have in place
cooperative research and development agreements with certain US
Department of Defense laboratories and other federally funded
government institutions. Certain regulatory measures apply to these
agreements which restrict the export of information and material
that may be used for military or intelligence applications by a
non-US person. Compliance with these regulatory measures may be
complex and limit commercial alternatives.
Impact : If certain portfolio companies were to breach
restrictions on the use of certain licensed technologies,
particularly those derived from federally funded research
facilities, this could materially impact upon the Group's ability
to license additional intellectual property from these
establishments. In certain circumstances, it may also lead to the
termination of existing licenses. In the event that this were to
happen, this could materially affect a number of the Group's
businesses, potentially harm the reputation and standing of the
Group and cause the termination of certain important relationships
with federally funded research institutions.
Mitigation :
-- Prior to licensing any technology under these agreements, the
Group's management seeks to identify the commercial and other
alternatives available for products and services associated with
such technology and innovations, and to ensure that there are
sufficient markets available to justify the capital investment.
-- Prior to the commercialisation process, the Group's
management seeks to obtain all the necessary clearances from
applicable regulatory bodies to ensure that the export of products
based upon the licensed IP is strictly in accordance with
government guidelines.
-- The Group, including certain of the portfolio companies,
employs a number of individuals with experience in working with
various government agencies.
-- Senior management is fully cognisant of the regulations and
sensitivities in relation to this issue, in particular with
International Traffic in Arms Regulations (ITAR) which regulate the
use of technologies for export, and has numerous mitigating actions
available should issues arise.
5. The Group operates in complex and specialised business
domains and requires highly qualified and experienced management to
implement its strategy successfully. All of the operations of the
Group are located in the United States, which is a highly
competitive employment market. Furthermore, given the relatively
small size of the senior management at the corporate level, the
Group is reliant on a small number of key individuals. As announced
on 31 March 2022 and updated on 31 May 2021, the Chairman of the
Company has announced his intention to resign from the board of
directors following the publication of these annual report and
accounts for the year ended 31 December 2021. The Company has an
urgent need to appoint new directors to the board in order to
ensure effective management to implement the execution of its
strategy.
Impact : There is a risk that the Group may lose key personnel,
or fail to attract or retain new personnel. The loss of key
personnel may negatively affect the Group's competitive advantage.
The Company also needs to identify and appoint new non-executive
directors to the board of the Company with sufficient experience to
execute the Company's strategy.
Mitigation :
-- The Company is working with its largest shareholders to
identify and appoint new non-executive directors to the board of
directors of the Company.
-- Senior management continually monitor and assess compensation
levels to ensure the Group remains competitive in the recruitment
market.
6. A large proportion of the overall value of the Group's
businesses may be concentrated in a small proportion of the Group's
businesses. If one or more of the intellectual property rights
relevant to a valuable business were terminated, this would have a
material adverse impact on the overall value of the Group's
businesses.
Impact : The termination of critical IP licenses would
materially impact the value of the portfolio company and have a
consequent effect on the value of the overall Group.
Mitigation :
-- In each portfolio company, the management is specifically
directed to pursue a policy of generating and patenting additional
intellectual property to both provide additional protection and
create direct IP ownership for the company.
-- Where possible, the Group seeks to negotiate intellectual
property ownership rights in any research and development agreement
it enters into with a network partner, such that the Group becomes
a part owner of the underlying IP.
7. The US Investment Company Act of 1940 regulates companies
which are engaged primarily in the business of investing,
reinvesting, owning, holding or trading in securities. Securities
issued by companies other than consolidated partner companies are
generally considered "investment securities" for purposes of the
Investment Company Act, unless other circumstances exist which
actively involve the company holding such interests in the
management of the underlying company.
Impact : If the Company is deemed to be an "investment company"
subject to regulation under the Investment Company Act, applicable
restrictions could make it impractical for the Group to continue
its business as contemplated and could have a material adverse
effect on its business. If anything were to happen which would
cause the Company to be deemed to be an investment company under
the Investment Company Act, requirements imposed by the Investment
Company Act, including limitations on capital structure, ability to
transact business with portfolio companies and ability to
compensate key employees, could make it impractical for it to
continue its business as currently conducted.
Mitigation :
-- The Company intends to monitor and conduct its operations so
that it will not be deemed to be an investment company under the
Investment Company Act.
-- The Company seeks to build value through its current
portfolio companies; it is not engaged primarily in the business of
investing, reinvesting, owning, holding or trading in securities
and does not own or propose to acquire investment securities above
prescribed thresholds under the Investment Company Act.
-- Currently the Company holds more than 50% of the voting
securities in one of its portfolio companies, and more than 20% of
all of its other portfolio companies (except TouchBistro, OcuTerra
and Concirrus), and intends to continue to try to maintain
significant influence in portfolio companies.
-- The Company seeks to maintain significant influence in
portfolio companies through a combination of the following:
o Rights to elect representatives to the board of directors,
with ability to exercise influence over the portfolio company's
business strategy, operating plans, budgets and key corporate
decisions;
o Legal rights, such as access to information (books and
records) and financial statements, liquidation preferences,
registrations rights, rights of first refusal, pre-emptive rights
and co-sale rights; and
o Protective provisions, such as rights to block certain
portfolio company actions.
8. As a result of the Group's strategy, the Group's overall
success is dependent on a limited, finite portfolio of businesses.
If one or more of such businesses were to fail, this would have a
material adverse impact on the overall value of the Group's
businesses and the Group's ability to return money to
shareholders.
Impact : The failure of one or more remaining Group businesses
would materially impact the overall value of the Group's portfolio
and have a consequent effect on the returns available to
shareholders.
Mitigation :
-- The Board is committed to engaging and working closely with
the remaining portfolio companies to provide guidance and advice as
they navigate funding, operational, and other needs.
-- The Board continues to monitor performance, progress, and
development of each portfolio company to critically assess the
return prospects of the remaining portfolio and make adjustments as
necessary.
9. Given its current cash and financial position, the Group
expects to remain operational through the next three years.
However, if the Group is unable to generate sufficient revenue,
appropriately manage expenses, attract co-investors to participate
in follow-on portfolio company financings, or generate a sale or
other liquidity event for any of its existing portfolio companies
or portfolio company interests prior to the end of such period,
then the Group's business, financial condition, results of
operations, prospects and future viability could be adversely
affected.
Impact : Lack of capital could restrict the Group's ability to
further fund, develop and commercialise its existing businesses. In
turn, this could ultimately lead to failure of individual portfolio
companies and loss of investment as well as failure of the Group as
a whole.
Mitigation :
-- The Board and Senior management continually seek to build and
maintain close relationships with its shareholder base and other
strategic partners at the Group level, and each portfolio company
continually seeks to engage in strategic relationships relevant to
their respective markets and to maintain current information on and
awareness of potential fund-raising and monetisation
strategies.
-- The Company strives to maintain majority ownership and/or
primary control over all of the portfolio companies and/or
portfolio company board representation, so that it can seek to
influence optimal capital allocation, use of cash, and fund-raising
strategy.
-- The Company has built a valuable portfolio of companies since its inception.
-- The Company continuously and critically reviews the progress
of its portfolio companies against pre-set milestones to ensure its
financial capital and human resource is properly allocated to the
more promising areas of its portfolio to help strengthen and
accelerate the Group's path to monetisation.
-- The Company recognises the need to identify and appoint new
non-executive directors to the board of the Company with sufficient
experience to execute its strategy. It is working with its largest
shareholders to identify and appoint new non-executive directors to
the board of directors of the Company.
COVID-19
As Allied Minds navigates the continued consequences of the
coronavirus pandemic, we continue to closely monitor, assess, and
respond to the impacts of the pandemic. The Group took several
actions to enable Allied Minds and its portfolio companies to
continue operating safely and effectively, including implementing
remote working environments, using virtual meeting platforms, and
reducing travel.
While the consequences of the coronavirus pandemic have had
varying degrees of commercial impact across the portfolio in the
past year, the actions and mitigation put in place by the Group
enabled day-to-day operations to continue effectively across the
portfolio. Allied Minds remains in close communication with all
customers, suppliers and partners to collaborate on how to best
support each other's needs in the post-pandemic environment.
Ukraine
The Board has considered the potential impact on the Group of
the current situation in Ukraine. The Group has no operations in
Russia, Ukraine or Belarus and, as such, does not expect and
direct, material impact on its business. Any possible impact to the
Group would likely manifest itself in inflationary pressure, and
deterioration in global economic performance and confidence. These
impacts are being monitored closely by the Board.
Corporate and Social Responsibility
Details on the Group's policies, activities and aims with regard
to its corporate and social responsibilities, including diversity,
are included in the Sustainability section on pages 53 to 56 and
are incorporated into this Strategic Report by reference.
This Strategic Report has been approved by the Board of
Directors.
ON BEHALF OF THE BOARD
Harry Rein
Chairman
14 June 2022
CONSOLIDATED STATEMENT OF COMPREHENSIVE LOSS
For the year ended 31 December Note 2021 2020
$ '000 $ '000
---------- ---------
Revenue 3 1,544 480
Operating expenses:
Cost of revenue 4,5 (443) (210)
Selling, general and administrative
expenses 4,5 (10,569) (10,497)
Research and development expenses 4,5 (2,650) (4,712)
Operating loss (12,118) (14,939)
Other income:
Gain on deconsolidation of subsidiary 11 14,213 -
Loss on investments held at fair
value (net) 11 (13,894) (31,934)
Other income 18 705 -
Other income /(expense) 1,024 (31,934)
Finance income 7 45 291
Finance cost 7 (255) (314)
Finance cost from IFRS9/ fair value
accounting 7 (2,578) (1,763)
---------- ---------
Finance loss, net (2,788) (1,786)
Share of net loss of associates accounted
for using the equity method 11 (2,362) (6,845)
---------- ---------
Loss before taxation (16,244) (55,504)
Taxation 23 - -
Loss for the period (16,244) (55,504)
Other comprehensive loss:
Items that may be reclassified subsequently
to profit or loss:
Foreign currency translation differences (41) (116)
Other comprehensive loss, net
of taxation (41) (116)
Total comprehensive loss for the
period (16,285) (55,620)
========== =========
Loss attributable to:
Equity holders of the parent (15,534) (53,025)
Non-controlling interests 15 (710) (2,479)
(16,244) (55,504)
========== =========
Total comprehensive loss attributable to:
Equity holders of the parent (15,575) (53,141)
Non-controlling interests 15 (710) (2,479)
(16,285) (55,620)
========== =========
Loss per share $ $
---------- ---------
Basic 8 (0.06) (0.22)
---------- ---------
Diluted 8 (0.06) (0.22)
---------- ---------
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
As of 31 December Note 2021 2020
$ '000 $ '000
------- ------------------------------
Non-current assets
Property and equipment 9 787 1,596
Investment at fair value 11,20 33,984 41,588
Right-of-use assets 19 414 651
Other financial assets 20 44 581
Total non-current assets 35,229 44,416
Current assets
Cash and cash equivalents 12 9,710 24,489
Trade and other receivables 13 5,912 5,816
Other financial assets 20 5,050 2,279
Total current assets 20,672 32,585
Total assets 55,901 77,000
======= ==============================
Equity
Share capital 14 3,767 3,767
Treasury shares 14 (738) -
Translation reserve 14 1,302 1,343
Accumulated profit 14 40,156 55,440
Equity attributable to owners
of the Company 44,487 60,550
Non-controlling interests 14,15 168 (2,264)
------- --------------------------------
Total equity 44,655 58,286
Non-current liabilities
Lease liabilities 19 213 806
Loans 17,18 - 1,440
Total non-current liabilities 213 2,246
Current liabilities
Trade and other payables 17 1,061 2,101
Deferred revenue 3 4,948 3,697
Loans 18 3,109 3,149
Preferred shares 16 1,255 6,497
Lease liabilities 19 660 1,024
Total current liabilities 11,033 16,468
Total liabilities 11,246 18,714
Total equity and liabilities 55,901 77,000
======= ================================
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
For the year ended 31 December 2021
Accumulated Total
Translation (Deficit)/ parent Non-controlling Total
reserve Earnings equity interests equity
Note Share capital Treasury shares $' 000 $' 000 $' 000 $' 000 $' 000
-------------------------- ------------------
Amount
$' Amount
Shares 000 Shares $' 000
----------------- ------- -------- -------- ------------ ------------ --------- ---------------- ---------
Balance at 31 December
2019 241,563,123 3,759 - 1,459 147,238 152,456 115 152,571
----------------- ------- -------- --------
Total comprehensive
loss for the year
Loss from continuing
operations - - - - - (53,025) (53,025) (2,479) (55,504)
Foreign currency
translation - - - - (116) - (116) - (116)
------------ ------------ --------- ---------------- ---------
Total comprehensive
loss for the year (116) (53,025) (53,141) (2,479) (55,620)
Issuance of ordinary
shares 14 624,862 8 - - - - 8 - 8
Loss arising from
change in
non-controlling
interest 15 - - - - - - - (18) (18)
Dividend payment 14 - - - - - (39,707) (39,707) - (39,707)
Equity-settled share
based payments 6 - - - - - 934 934 118 1,052
----------------- ------- -------- -------- ------------ ------------ --------- ---------------- ---------
Balance at 31 December
2020 242,187,985 3,767 - - 1,343 55,440 60,550 (2,264) 58,286
----------------- ------- -------- -------- ------------ ------------ --------- ---------------- ---------
Total comprehensive
loss for the period
Loss from continuing
operations - - - - - (15,534) (15,534) (710) (16,244)
Foreign currency
translation - - - - (41) - (41) - (41)
------------ ------------ --------- ---------------- ---------
Total comprehensive
loss for the period - - - - (41) (15,534) (15,575) (710) (16,285)
Loss arising from
change in
non-controlling
interest 15 - - - - - - - (96) (96)
Repurchase of ordinary
shares 14,15 - - (2,538) (738) - - (738) - (738)
Deconsolidation of
subsidiary 15 - - - - - - - 3,207 3,207
Equity-settled share
based payments 6 - - - - - 250 250 31 281
----------------- ------- -------- -------- ------------ ------------ --------- ---------------- ---------
Balance at 31 December
2021 242,187,985 3,767 (2,538) (738) 1,302 40,156 44,487 168 44,655
================= ======= ======== ======== ============ ============ ========= ================ =========
CONSOLIDATED STATEMENT OF CASH FLOWS
For the year ended 31 December 2021 2020
Note $ '000 $ '000
--------- ---------
Cash flows from operating activities:
Loss for the year (16,244) (55,504)
Adjustments to reconcile net loss to net cash
used in operating activities:
Depreciation 9,19 839 819
Amortisation 10 - 197
Impairment losses on property and equipment 9 458 -
Share-based compensation expense 5,6 281 1,052
Forgiveness of Paycheck Protection Program (PPP) loan 18 (443) -
Loss on investments held at fair value 11,20 13,894 31,934
Gain on deconsolidation of subsidiary 11 (14,213) -
Share of net loss of associate 11 2,362 6,845
Other income 9 (262) -
Changes in working capital:
Increase in trade and other receivables 13 (96) (114)
Decrease/(increase) in other assets 693 (874)
Decrease in trade payables 17 (78) (876)
Decrease in accrued expenses 17 (691) (1,643)
Increase in deferred revenue 3 1,386 240
Increase/(decrease) in other liabilities 517 (780)
Unrealised gain on foreign currency transactions (41) (116)
Other finance expense 7 2,578 1,763
Net cash used in operating activities (9,060) (17,057)
--------- ---------
Cash flows from investing activities:
Purchases of property and equipment, net of disposals 9 (185) (564)
Purchase of investments at fair value 11 (5,283) (10,855)
Receipt of payment for finance sub-lease 19 45 78
Cash derecognised upon loss of control over subsidiary 11 (13,326) -
Net cash used in investing activities (18,749) (11,341)
--------- ---------
Cash flows from financing activities:
Proceeds from issuance of convertible notes 18 - 2,981
Receipt of PPP loan 18 259 184
Payment of lease liability 19 (1,100) (1,150)
Dividend payment 14 - (39,707)
Payments to repurchase ordinary shares 14 (738) -
Proceeds from issuance of share capital 6,14 - 8
Proceeds from issuance of preferred shares in subsidiaries 16 14,609 -
Net cash provided by /(used in) financing activities 13,030 (37,684)
--------- ---------
Net decrease in cash and cash equivalents, and restricted cash (14,779) (66,082)
Cash and cash equivalents, beginning of the period 24,489 90,571
Cash and cash equivalents, end of the period 9,710 24,489
========= =========
NOTES TO THE CONSOLIDATED FINANCIAL INFORMATION
(1) Accounting Policies
Basis of Preparation
The financial information set out in this document does not
constitute the Group's statutory accounts for the years ended 31
December 2020 or 2021. Statutory accounts for the years ended 31
December 2020 and 31 December 2021, which were approved by the
directors on 14 June 2022 have been reported on by the Independent
Auditor. The Independent Auditor's Reports on the Annual Report and
Financial Statements for each of 2020 and 2021 were unqualified,
did not draw attention to any matters by way of emphasis, and did
not contain a statement under 498(2) or 498(3) of the Companies Act
2006.
Statutory accounts for the year ended 31 December 2020 have been
filed with the Registrar of Companies. The statutory accounts for
the year ended 31 December 2021 will be delivered to the Registrar
of Companies in due course and will be posted to shareholders
shortly, and thereafter will be available from the Group's
registered office at Beaufort House, 51 New North Road, Exeter,
Devon, England, United Kingdom, EX4 4EP, and from the Group's
website http://www.alliedminds.com/investor/.
The financial information set out in these results has been
prepared using the recognition and measurement principles of
International Accounting Standards, International Financial
Reporting Standards and Interpretations in conformity with UK
adopted international accounting standards ('IFRS'). The accounting
policies adopted in these results have been consistently applied to
all the years presented and are consistent with the policies used
in the preparation of the financial statements for the year ended
31 December 2020, except for those that relate to new standards and
interpretations effective for the first time for periods beginning
on (or after) 1 January 2021. There are deemed to be no new
standards, amendments and interpretations to existing standards,
which have been adopted by the Group, that have had a material
impact on the financial statements.
The Group's financial information has been presented in US
Dollars (USD).
Basis of Measurement
The consolidated financial statements have been prepared on the
historical cost basis except that the following assets and
liabilities are stated at their fair value: investments held at
fair value and financial instruments classified as fair value
through the profit or loss.
Use of Judgments and Estimates
In preparing these consolidated financial statements, management
has made judgments, estimates and assumptions that affect the
application of the Group's accounting policies and the reported
amounts of assets, liabilities, income and expenses. Actual results
may differ from these estimates. Estimates and underlying
assumptions are reviewed on an on-going basis. Revisions to
estimates are recognised prospectively. The effects on the amounts
recognised in the consolidated financial statements, or on other
alternative performance measures, is included in the following
notes:
Significant estimates made include:
-- Note 11 and 16 - Valuation of financial instruments measured
at fair value through profit/loss: There is uncertainty in
estimating the fair value of subsidiary note payables, subsidiary
preferred shares, and convertible note assets and investments
carried at fair value through profit and loss (FVTPL) according to
IFRS 9 at initial recognition and upon subsequent measurement. This
includes determining the appropriate valuation methodology and
making certain estimates including future earnings potential of the
subsidiary businesses, appropriate discount rate and earnings
multiple to be applied, marketability, the probability weighting of
the scenarios and other industry and company specific risk
factors.
Significant judgements made include:
-- Note 11 - there is judgement in considering whether the power
to control the subsidiary exists or retaining significant influence
as it is dependent on certain factors including the voting power
the entity exercises over the company, the proportion of seats the
company controls on the board and the investees dependence on the
investor for funding, knowledge and its operations. Further to the
above the group has considered its position under IFRS10 in respect
of whether it is an investment entity for the purposes of this
standard. Management have reviewed the operations of the group in
line with the standard, and whilst there are characteristics which
indicate the group could be considered an investment company, the
underlying measurement of success for the consolidated portfolio
investments is progress in relation to key strategic milestones in
bringing their products to market and not the fair value of the
business. Based on this management have judged the business to not
be an investment entity and consolidate its subsidiaries under
IFRS10.
-- Note 11 - as the entities in the group progress they require
further external funding which in some scenarios reduces the
Group's shareholding to an extent that it loses control under IFRS
10 which results in them no longer being able to consolidate the
entity. There is a further significant judgement in relation to
whether the shares are accounted for as an investment in associate
per IAS 28 or as a financial asset per IFRS 9 and therefore held at
fair value, i.e. whether the Group maintain significant influence
over the Company. This judgement includes, among others, an
assessment of whether the Company has representation on the board
of directors of the investee, whether the Company participates in
the policy making processes of the investee, whether there is any
interchange of managerial personnel, whether there is any essential
technical information provided to the investee and if there are any
transactions between the Company and the investee.
-- Note 16 and 20 - financial instrument liability
classification: when determining the classification of financial
instruments in terms of liability or equity. These judgements
include an assessment whether the financial instrument include any
embedded derivative features, whether they include a contractual
obligations upon the Group to deliver cash or other financial
assets or to exchange financial assets or financial liabilities
with another party, and whether that obligation will be settled by
the Company's exchanging a fixed amount of cash or other financial
assets for a fixed number of its own equity instruments. Further
information about these critical judgments is included below under
Financial Instruments.
-- Note 3 - revenue recognition: in determining the correct
amount of revenue to be recognised, the Directors make estimates of
the fair values of each component of a contract to be able to
allocate the overall consideration to each component based on the
relative fair value method or make estimates of future costs when
applying the inputs method.
-- Note 3 - timing of revenue recognition: making certain
judgements when determining the appropriate accounting treatment of
key customer contract terms in accordance with the applicable
accounting standards and in determining whether revenue should be
recognised at a point in time or over a period of time.
Other estimates and judgments:
-- Note 19 - discount rate used in lease treatment: in
determining the appropriate discount rate to calculate the present
value of lease payments. These judgements include an assessment of
what Group's incremental borrowing rate is where there is no rate
implicit within the lease. The incremental borrowing rate will take
into account the credit standing of the lessee, the length of the
lease, the nature and quality of the collateral provided and the
economic environment in which the transaction occurs.
Going Concern
The Directors have taken proactive cost management measures that
include reduction in expenses of the management function of the
head office at the parent level. They have also decided to focus
exclusively on supporting the six existing portfolio companies,
albeit do not make or have and enforceable financial or working
capital commitments, and maximising monetisation opportunities for
portfolio company interests, and not to deploy any capital into any
new portfolio companies. In the event of successful monetisation
events from the sale of portfolio companies or portfolio company
interests, the Directors anticipate distributing the net proceeds
to shareholders, after due consideration of potential follow-on
investment opportunities within the existing portfolio and working
capital requirements. The Directors expect this strategy to take at
least two years to be fully implemented, and as a matter of good
governance, will continue to keep this strategy under review at
appropriate intervals. They have prepared trading and cash flow
forecasts for the parent through 2025. Reflecting this revised
strategy, although the Group is currently loss making and is likely
to continue to be so, at least in the short term, after making
enquiries and considering the impact of risks and opportunities on
expected cash flows, and given the fact that the Group has $9.7
million of available funds in the form of cash and cash equivalents
as at 31 December 2021, and added to this with the sale if the
holding in TouchBistro post year end for consideration of $3.9
million, the Directors have a reasonable expectation that the Group
has adequate cash to continue in operational existence for a period
of not less than 12 months from the date of approval of the
financial statements. Furthermore, the directors have considered
the timeline of when it plans to dispose of, divest or reinvest in
its portfolio companies and there is no intention to cease trading
or liquidate the business for the period under the going concern
review.
Though the majority of the Company's operations are in the
United States and the functional currency of the group is the U.S.
dollar, Allied Minds is based in the United Kingdom and therefore
susceptible to various international risks such as economic
headwinds, including inflationary pressure, interest rates and
component price increases, as well as changes in political and
regulatory requirements. These risks are continuously monitored and
reviewed by management. The Group cannot predict all future events
or conditions, however, the directors have concluded that there are
no material uncertainties that could cast significant doubt over
the ability of the Group to continue as a going concern for at
least the going concern period as assessed above and the Company's
existing measures are sufficient to mitigate the inherent risks to
its business model.
The Directors have also put in measures to mitigate against the
risks to the business due to the continued impact of COVID-19. Any
continued impact from COVID-19 or the situation in Ukraine will not
affect Allied Minds from a going concern perspective. In fact, it
is expected that the impact of COVID-19 will continue to add cost
savings during 2022 as a result of suspension of most travel for
board meetings, investor meetings and the 2022 Annual General
Meeting. These savings have a positive impact on Allied Minds as a
going concern.
The Directors are conscious of the recent board changes and the
need to appoint additional directors to the board of the Company.
The Directors are working closely with the Company's largest
shareholders to identify and recruit new directors to the board of
the Company.
The directors' judgement concludes there is no material
uncertainty in relation to going concern. For this reason, they
have adopted the going concern basis in preparing the financial
statements.
Basis of Consolidation
Allied Minds Plc was formed on 15 April 2014 and the
consolidated financial statements for each of the years ended 31
December 2021 and 2020 comprises the financial statements of Allied
Minds Plc and its subsidiaries.
Subsidiaries
The financial information of the subsidiaries is prepared for
the same reporting period as the parent Company, using consistent
accounting policies. Subsidiaries are entities controlled by the
Group. The Group controls an entity when it is exposed to, or has
rights to, variable returns from its involvement with the entity
and has the ability to affect those returns through its power over
the entity. The financial statements of subsidiaries are included
in the consolidated financial statements from the date that control
commences until the date that control ceases. Losses applicable to
the non-controlling interests in a subsidiary are allocated to the
non-controlling interests even if doing so causes the
non-controlling interests to have a deficit balance.
Changes in the Group's interest in a subsidiary that do not
result in a loss of control are accounted for as equity
transactions. Where the Group loses control of a subsidiary, the
assets and liabilities are derecognised along with any related NCI
and other components of equity. Any resulting gain or loss is
recognised in profit or loss. Any interest retained in the former
subsidiary is measured at fair value under IFRS 9 when control is
lost and it will be assessed whether significant influence remains.
Where this is the case the ongoing accounting will be under IAS 28,
if significant influence is also lost, the remaining investment is
accounted for under IFRS 9.
Associates
Associates are those entities in which the Group has significant
influence, but not control, over the financial and operating
policies. Significant influence is presumed to exist when the Group
holds between 20 and 50 percent of the voting power of another
entity. It is also evidenced in one or more of the following
ways:
-- representation on the board of directors or equivalent governing body of the investee;
-- participation in policy-making processes, including
participation in decisions about dividends or other
distributions;
-- material transactions between the entity and its investee;
-- interchange of managerial personnel; or
-- provision of essential technical information.
Associates are accounted for using the equity method (equity
accounted investees) and are initially recognised at cost. The
Group's investment includes goodwill identified on acquisition, net
of any accumulated impairment losses. The consolidated financial
statements include the Group's share of the total comprehensive
income and equity movements of equity accounted investees, from the
date that significant influence commences until the date that
significant influence ceases. When the Group's share of losses
exceeds its interest in an equity accounted investee, the Group's
carrying amount is reduced to $nil or up to additional losses are
provided for, and a liability is recognised, to the extent that the
entity has incurred legal or constructive obligations or made
payments on behalf of the associate. Recognition of further losses
is discontinued except to the extent that the Group has incurred
legal or constructive obligations or made payments on behalf of an
investee. To the extent the Group holds interests in associates
that are not providing access to returns underlying ownership
interests and are more akin to debt like securities, the instrument
held by Allied Minds is accounted for in accordance with IFRS
9.
Transactions eliminated on consolidation
Intra-group balances and transactions, and any unrealised income
and expenses arising from intra- group transactions, are
eliminated. Unrealised gains arising from transactions with
equity-accounted investees are eliminated against the investment to
the extent of the Group's interest in the investee. Unrealised
losses are eliminated in the same way as unrealised gains, but only
to the extent that there is no evidence of impairment.
Changes of non-controlling interests
Non-controlling interests ("NCI") are measured at their
proportionate share of the acquiree's identifiable net assets at
the acquisition date. Changes in the Group's interest in a
subsidiary that do not result in a loss of control are accounted
for as equity transactions.
Changes of non-controlling interests that do not result in a
change of control are accounted for as transactions with owners in
their capacity as owners and therefore no goodwill is recognised as
a result of such transactions. The adjustments to non-controlling
interests are based on a proportionate amount of the net assets of
the subsidiary. Any difference between the price paid or received
and the amount by which non-controlling interests are adjusted is
recognised directly in equity and attributed to the owners of the
parent.
Functional and Presentation Currency
These consolidated financial statements are presented in US
dollars, which is the functional currency of most of the entities
in the Group. The parent has a functional currency of GBP. All
amounts have been rounded to the nearest thousand unless otherwise
indicated.
Foreign Currency
Transactions in foreign currencies are translated to the
respective functional currencies of Group entities at the foreign
exchange rate ruling at the date of the transaction. Monetary
assets and liabilities denominated in foreign currencies at the
balance sheet date are retranslated to the functional currency at
the foreign exchange rate ruling at that date. Foreign exchange
differences arising on translation are recognised in the
consolidated statement of comprehensive loss. Non-monetary assets
and liabilities that are measured in terms of historical cost in a
foreign currency are translated using the exchange rate at the date
of the transaction. Non-monetary assets and liabilities denominated
in foreign currencies that are stated at fair value are
retranslated to the functional currency at foreign exchange rates
ruling at the dates the fair value was determined.
The assets and liabilities of foreign operations, including fair
value adjustments arising on consolidation, are translated to the
Group's presentational currency (US dollar) at foreign exchange
rates ruling at the balance sheet date. The revenues and expenses
of foreign operations are translated at an average rate for the
year where this rate approximates to the foreign exchange rates
ruling at the dates of the transactions. Exchange differences
arising from this translation of foreign operations are reported as
an item of other comprehensive income and accumulated in the
translation reserve or non- controlling interest, as the case may
be. When a foreign operation is disposed of, such that control,
joint control or significant influence (as the case may be) is
lost, the entire accumulated amount in the translation reserve, net
of amounts previously attributed to non-controlling interests, is
reclassified to profit or loss as part of the gain or loss on
disposal. When the Group disposes of only part of its interest in a
subsidiary that includes a foreign operation while still retaining
control, the relevant proportion of the accumulated amount is
reattributed to non-controlling interests. When the Group disposes
of only part of its investment in a subsidiary or an associate that
includes a foreign operation while still retaining significant
influence or joint control, the relevant proportion of the
cumulative amount is reclassified to profit or loss.
Cash and Cash Equivalents
Cash and cash equivalents include all highly liquid instruments
with original maturities of three months or less.
Financial Instruments
Classification - Financial Assets
IFRS 9 contains a classification and measurement approach for
financial assets that reflects the business model, in which assets
are managed, and their cash flow characteristics. IFRS 9 contains
three principal classification categories for financial assets:
measured at amortised cost, fair value through other comprehensive
income ("FVOCI") and fair value through profit or loss ("FVTPL").
Under IFRS 9, derivatives embedded in contracts where the host is a
financial asset in the scope of the standard are never bifurcated.
Instead, the hybrid as a whole is assessed for classification.
Under IFRS 9 all fair value changes of assets designated as at
fair value through profit or loss are generally presented in profit
or loss.
Cash and cash equivalents : Represent basic cash balances in
banks used to fund operations. These are classified as assets at
amortised cost under IFRS 9.
Trade Receivables : Under IFRS 9 trade receivables that do not
have a significant financing component have to be initially
recognised at their transaction price rather than at fair value.
The Group initially recognises receivables and deposits on the date
that they are originated at their transaction price, which is the
same as their fair value. As such, Trade and other receivables are
classified as assets at amortised cost under IFRS 9.
Short-term notes : The short-term note from an associate, since
its contractual terms do not consist solely of cash flow payments
of principal and interest on the principal amount outstanding, is
initially and subsequently measured at fair value, with changes in
fair value recognized through profit or loss under IFRS 9. The
Group designates the SAFE note assets at FVTPL under IFRS 9. Hence,
any gains and losses on the these notes are recognised in profit or
loss and are measured in the same way as investments as fair value
above.
Security and other deposits : These generally represent security
deposits paid by the Group to landlords as part of operating lease
commitments. As the Company's objective is that those deposits will
be collected back, they are classified as assets at amortised cost
under IFRS 9.
Investments at fair value: Reflect investments made by the Group
in non-derivative instruments of the investees that are designated
in this category or not classified in any other category. These
financial assets are initially measured at fair value and
subsequently re-measured at fair value at each reporting date, and
on derecognition. The Company elects if the gain or loss will be
recognised in the Consolidated Statements of Comprehensive Income/
(Loss) in Other Comprehensive Income/(Loss) or through the profit
and loss on an instrument by instrument basis. Investments at fair
value are presented in the Consolidated Statements of Financial
Position as non-current assets, unless the Group intends to dispose
of them within 12 months after the end of the reporting period. If
the investments at fair value continue to be held for the same
long-term strategic purposes, per the application of IFRS 9, the
Group may elect then to classify them as FVOCI or FVTPL. The Group
classifies them as FVTPL. In this case, all fair value gains and
losses would be recognised in profit or loss as they arise,
increasing volatility in the Group's profits. These financial
assets do not have exposure to credit risk and are not considered
credit-impaired. As a result, there are no adjustments considered
for movement in credit risk as this is not applicable within the
specific valuation frameworks utilised for the fair values of the
Group's preferred stock assets. To the extent the Group holds
interests in associates that are not providing access to returns
underlying ownership interests and are more akin to debt like
securities, the instrument held by Allied Minds is accounted for in
accordance with IFRS 9.
Classification - Financial Liabilities
Under IFRS 9 all fair value changes of liabilities designated as
at fair value through profit or loss are generally presented in
profit or loss.
The Group designates the subsidiary preferred shares liability
at FVTPL under IFRS 9. Hence, any gains and losses on the preferred
shares liability are recognised in profit or loss, unless they
relate to changes in the entity's own credit risk for financial
liability designated as at fair value through profit or loss. The
effect of changes in the entity's own credit risk in the fair value
of the financial liabilities are presented in other comprehensive
income. For the underlying financial instruments no adjustments are
considered for movement in credit risk as this is not applicable
within the specific valuation frameworks utilized for the fair
values of the Group's preferred share liability.
Trade and other payables and loans are designated at amortised
cost under IFRS 9.
Impairment
IFRS 9 includes a 'forward looking expected credit loss' ("ECL")
model. The impairment methodology applied depends on whether there
has been a significant increase in credit risk. For trade
receivables, the group applies the simplified approach permitted by
IFRS 9, which requires expected lifetime losses to be recognised
from initial recognition of the receivables.
Financial Instruments Issued by the Group
Under IAS 32, financial instruments issued by the Group are
treated as equity only to the extent that they meet the following
two conditions:
-- they include no contractual obligations upon the Group to
deliver cash or other financial assets or to exchange financial
assets or financial liabilities with another party under conditions
that are potentially unfavourable to the Group; and
-- where the instrument will or may be settled in the Company's
own equity instruments, it is either a non-derivative that includes
no obligation to deliver a variable number of the Company's own
equity instruments or is a derivative that will be settled by the
Company's exchanging a fixed amount of cash or other financial
assets for a fixed number of its own equity instruments.
To the extent that this definition is not met, the financial
instrument is classified as a financial liability. Where the
instrument so classified takes the legal form of the Company's own
shares, the amounts presented in the financial information for
share capital and merger reserve account exclude amounts in
relation to those shares.
Where a financial instrument that contains both equity and
financial liability components exists, these components are
separated and accounted for individually under the above
policy.
Paycheck Protection Program (PPP) loan
The US CARES Act created the Paycheck Protection Program (PPP)
to provide qualifying small businesses with necessary funds to
support their operations during the COVID-19 pandemic. Entities
have to meet certain eligibility requirements to receive PPP loans,
and they must maintain specified levels of payroll and employment
to have the loans forgiven. The conditions are subject to audit by
the US government, but entities that borrow less than $2 million
will be deemed to have met the initial eligibility
requirements.
Under IAS 20, Accounting for Government Grants and Disclosure of
Government Assistance, the initial receipt of PPP loans is
recognized as a liability. This liability can be derecognized when
there is "reasonable assurance" that the loan conditions will be
met and forgiveness will be granted. Once forgiven, the company
records the amount as other income.
Share Capital
Ordinary shares are classified as equity. The Group considers
its capital to comprise share capital, share premium, merger
reserve, translation reserve, and accumulated deficit.
Property and Equipment
Property and equipment is stated at cost less accumulated
depreciation and any accumulated impairment losses. Cost includes
expenditure that is directly attributable to the acquisition of the
asset. Assets under construction represent machinery and equipment
to be used in operations, R&D activities, or to be leased to
customers once completed.
When parts of an item of property and equipment have different
useful lives, they are accounted for as separate items (major
components) of property and equipment. Depreciation is calculated
using the straight-line method over the estimated useful lives of
the related assets:
Computers and electronics 3 years
Furniture and fixtures 5 years
Machinery and equipment 5 -20 years
Under construction Not depreciated until transferred into use
Leasehold improvements Shorter of the lease term or estimated
useful life of the asset
Right-of-Use Assets Shorter of the lease term or estimated
useful life of the asset
Depreciation methods, useful lives and residual values are
reviewed at least annually and adjusted if appropriate.
The Directors have considered the value of fixed assets without
revaluing them.
The Directors are satisfied that the aggregate value of those
assets at the time in question is or was not less than aggregate
amount at which they are or were for the time being stated in the
company's accounts.
Intangible Assets
Software
Software intangible assets that are acquired by the Group and
have finite useful lives are measured at cost less accumulated
amortisation and any accumulated impairment losses.
Finite-lived intangible assets are amortised on a straight-line
basis over their estimated useful lives, from the date that they
are available for use. Intangible assets which are not yet
available for use (and therefore not amortised) are tested for
impairment at least annually.
Amortisation
Amortisation is charged to the consolidated statement of
comprehensive loss on a straight-line basis over the estimated
useful lives of intangible assets unless such lives are indefinite.
Intangible assets with an indefinite useful life and goodwill are
systematically tested for impairment at each balance sheet date.
Other intangible assets are amortised from the date they are
available for use. Amortisation methods, useful lives and residual
values are reviewed at least annually and adjusted if
appropriate.
The estimated useful lives of the Group's intangible assets are
as follows:
Software 2 years
Leases
IFRS 16 is a single, on-balance sheet lease accounting model for
lessees and requires leases to be accounted for using a
right-of-use model, which recognises that, at the date of
commencement, a lessee has a financial obligation to make lease
payments to the lessor for the right to use the underlying asset
during the lease term. The lessee recognises a corresponding
right-of-use asset related to this right.
Upon adoption, the Group applied the following practical
expedients:
-- excluding initial direct costs from the right-of-use assets;
-- use hindsight when assessing the lease term;
-- not reassessing whether a contract is or contains a lease; and
-- not separating the lease components from the non-lease components in lease contracts.
The Group accounts for lease payments as an expense on a
straight-line basis over the life of the lease for:
-- Leases with a term of 12 months or less and containing no purchase options; and
-- Leases where the underlying asset has a value of less than $5,000.
The lease liability is initially measured at the present value
of the remaining lease payments at the transition date or date of
entering the lease, discounted by using the rate implicit in the
lease. If this rate cannot be readily determined, the Group used
its incremental borrowing rate. The right-of-use asset is
depreciated on a straight-line basis and the lease liability will
give rise to an interest charge.
Finance leases will continue to be treated as finance leases. In
November 2020 the Company relocated its corporate headquarters as
part of management's initiative to minimise headquarters expenses.
As a result, starting November 2020, the Company entered into a
sublease for the remaining period of the head lease.
Under IFRS 16, this sublease led to the de-recognition of the
right of use asset and the recognition of an investment receivable
in respect of this sublease. The lease liability remains in respect
of the head lease as a lease liability on the balance sheet.
The Group recognised lease liabilities of $0.9 million and $0.4
million in lease assets at 31 December 2021. Those rights and
obligations are primarily related to operating leases for office
and laboratory space.
BridgeComm entered into a new lease in 2021. Further information
regarding the right of use asset and lease liability can be found
in Note 19.
Taxation
Tax on the profit or loss for the year comprises current and
deferred tax. Tax is recognised in the income statement except to
the extent that it relates to items recognised directly in equity,
in which case it is recognised in equity.
Current Income Tax
Current tax is the expected tax payable or receivable on the
taxable income or loss for the year, using tax rates enacted or
substantially enacted at the reporting date, and any adjustment to
tax payable in respect of previous years.
Deferred Income Tax
Deferred tax is recognised in respect of temporary differences
between the carrying amounts of assets and liabilities for
financial reporting purposes and the amounts used for taxation
purposes. Deferred tax assets are recognised for unused tax losses,
unused tax credits and deductible temporary differences to the
extent that it is probable that future taxable profits will be
available against which they can be used. Deferred tax assets are
reviewed at each reporting date and are reduced to the extent that
it is no longer probable that the related tax benefit will be
realised.
Deferred tax is measured at the tax rates that are expected to
be applied to temporary differences when they reverse, using tax
rates enacted or substantively enacted at the reporting date.
Deferred tax assets and liabilities are offset if there is a
legally enforceable right to offset current tax liabilities and
assets, and they relate to taxes levied by the same tax authority
on the same taxable entity, or on different tax entities where the
Group intends to settle current tax liabilities and assets on a net
basis or their tax assets and liabilities will be realised
simultaneously.
Deferred taxes are recognised in profit or loss except to the
extent that it relates to items recognised directly in equity or in
other comprehensive income.
Impairment
Impairment of Non-Financial Assets
Non-financial assets consist of property and equipment and
intangible assets with finite lives and such intangible assets
which are not yet available for use.
The Group reviews the carrying amounts of its property and
equipment and finite-lived intangibles at each reporting date to
determine whether there is any indication of impairment. If any
such indication exists, then the asset's recoverable amount is
estimated. Intangible assets which are not yet available for use
are tested annually for impairment.
For impairment testing, assets are grouped together into the
smallest group of assets that generates cash inflows from
continuing use that are largely independent of the cash inflows of
other assets or cash-generating units ("CGUs").
The recoverable amount of an asset or CGU is the greater of its
value in use and its fair value less costs to sell. Value in use is
based on the estimated future cash flows, discounted to their
present value using a pre-tax discount rate that reflects current
market assessments of the time value of money and the risks
specific to the asset or CGU.
An impairment loss is recognised in profit and loss if the
carrying amount of an asset or CGU exceeds its recoverable amount.
Impairment losses are allocated to reduce the carrying amounts of
assets in a CGU on a pro rata basis.
Impairment of Financial Assets
The company recognises loss allowances for expected credit
losses (ECLs) on financial assets measured at amortised cost.
The company measures loss allowances at an amount equal to
lifetime ECL, except for other debt securities and bank balances
for which credit risk (i.e. the risk of default occurring over the
expected life of the financial instrument) has not increased
significantly since initial recognition, which are measured as
12-month ECL.
Loss allowances for trade receivables and contract assets are
always measured at an amount equal to lifetime ECL.
When determining whether the credit risk of a financial asset
has increased significantly since initial recognition and when
estimating ECL, the company considers reasonable and supportable
information that is relevant and available without undue cost or
effort. This includes both quantitative and qualitative information
and analysis, based on the company's historical experience and
informed credit assessment and including forward-looking
information.
Share-based Payments
Share-based payment arrangements in which the Parent receive
goods or services as consideration for their own equity instruments
are accounted for as equity-settled share-based payment
transactions, regardless of how the equity instruments are obtained
by the Group or its subsidiaries. Grants of equity instruments
under the subsidiary stock option incentive plans are accounted for
as equity-settled in the consolidated accounts of the parent and
are reflected in equity as a credit to Non-Controlling
Interest.
The grant date fair value of share-based payment awards granted
to employees is recognised as an employee expense, with a
corresponding increase in equity, over the period that the
employees become unconditionally entitled to the awards. The fair
value of the options granted is measured using an option pricing
valuation model, taking into account the terms and conditions upon
which the options were granted. The amount recognised as an expense
is adjusted to reflect the actual number of awards for which the
related service and non-market vesting conditions are expected to
be met, such that the amount ultimately recognised as an expense is
based on the number of awards that do meet the related service and
non-market performance conditions at the vesting date. For
share-based payment awards with market or non-vesting conditions,
the grant date fair value of the share-based payment is measured to
reflect such conditions and there is no true-up for differences
between expected and actual outcomes.
Employee Benefits
Short-term Employee Benefits
Short-term employee benefit obligations are measured on an
undiscounted basis and are expensed as the related service is
provided. A liability is recognised for the amount expected to be
paid if the Group has a present legal or constructive obligation to
pay this amount as a result of past service provided by the
employee, and the obligation can be estimated reliably.
Defined Contribution Plans
A defined contribution plan is a post-employment benefit plan
under which an entity pays fixed contributions into a separate
entity and has no legal or constructive obligation to pay further
amounts. Obligations for contributions to defined contribution
plans are recognised as an employee benefit expense in the periods
during which related services are rendered by employees. Prepaid
contributions are recognised as an asset to the extent that a cash
refund or a reduction in future payments is available.
Phantom Plan
The Phantom Plan is a cash settled bonus plan. Expense is
accrued when it is determined that it is probable that a payment
will be made and when the amount can be reasonably estimated.
Provisions
A provision is recognised in the balance sheet when the Group
has a present legal or constructive obligation as a result of a
past event, that can be reliably measured and it is probable that
an outflow of economic benefits will be required to settle the
obligation. Provisions are determined by discounting the expected
future cash flows at a pre-tax rate that reflects risks specific to
the liability.
Revenue Recognition
The Group recognises revenue to depict the transfer of promised
goods to customers in an amount that reflects the consideration to
which it expects to be entitled in exchange for those goods. In
order to achieve this, the Group uses the five step model outlined
in IFRS 15: 1) to identify the contract with the customer; 2)
identify the performance obligation(s) in the contract; 3)
determine the transaction price; 4) allocate the transaction price
to the performance obligation(s); and 5) recognise revenue when (or
as) we satisfy the performance obligation(s).
IFRS 15 implements a uniform method of recognising revenue based
on the actual contract and performance obligation. Under IFRS 15,
revenue is recognised when the Company satisfies a performance
obligation by transferring a promised good or service to its
customer. As such, the amount of revenue recognised is the amount
allocated to the satisfied performance obligation. A performance
obligation may be satisfied at a point in time (typically for
promises to transfer goods to a customer) or over time (typically
for promises to transfer services to a customer).
Determining the timing of the transfer of control - at a point
in time or over time - requires judgement. Based on Group's
assessment, it was concluded that the majority of the Company's
projects that:
-- Render a service is performed on a time and materials basis
and revenue is recognised as services are provided based on actual
hours worked for a set period. The performance obligations
identified within these projects are distinct and meet the criteria
resulting in transfer of control over time.
-- Sell goods , revenue is recognised when the control of the
products were transferred to the customer. The performance
obligations identified within these projects are distinct and meet
the criteria resulting in transfer of control at a point in
time.
Refer to Note 3, "Revenue Recognition," for additional
information related to the revenue recognised in the consolidated
statements of operations.
Finance Income and Finance Costs
Finance income mainly comprises interest income on funds
invested and foreign exchange gains. Finance costs mainly comprise
fair value movements on preferred share liabilities, loan interest
expense and foreign exchange losses. Interest income and interest
payable are recognised as they accrue in profit or loss, using the
effective interest method.
Fair Value Measurements
A number of the Group's accounting policies and disclosures
require the measurement of fair values, for both financial and
non-financial assets and liabilities.
When measuring the fair value of an asset or a liability, the
Group uses market observable data as far as possible. Fair values
are categorised into different levels in a fair value hierarchy
based on the inputs used in the valuation techniques as
follows:
-- Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities.
-- Level 2: inputs other than quoted prices included in Level 1
that are observable for the asset or liability, either directly
(i.e. as prices) or indirectly (i.e. derived from prices).
-- Level 3: inputs for the asset or liability that are not based
on observable market data (unobservable inputs).
If the inputs used to measure the fair value of an asset or a
liability might be categorised in different levels of the fair
value hierarchy, then the fair value measurement is categorised in
its entirety in the same level of the fair value hierarchy as the
lowest level input that is significant to the entire
measurement.
The Group recognises transfers between levels of the fair value
hierarchy at the end of the reporting period during which the
change has occurred.
The carrying amount of cash and cash equivalents, accounts
receivable, deposits, accounts payable, accrued expenses and other
current liabilities in the Group's Consolidated Statements of
Financial Position approximates their fair value because of the
short maturities of these instruments.
Operating Segments
Allied Minds determines and presents operating segments based on
the information that internally is provided to the executive
management team, the body which is considered to be Allied Minds'
Chief Operating Decision Maker ("CODM").
An operating segment is a component of Allied Minds that engages
in business activities from which it may earn revenues and incur
expenses, including revenues and expenses that relate to
transactions with any of the Allied Minds' other components. The
operating segment's operating results are reviewed regularly by the
CODM to make decisions about resources to be allocated to the
segment, to assess its performance, and for which discrete
financial information is available.
Newly adopted standards
New standards and interpretations adopted in the current year
that did not have a material impact on the Company's financial
statements were as follows:
Effective date New standards or amendments
1 January 2021 Amendments to References to Conceptual Framework in IFRS Standards
--------------------------------------------------------------------
Definition of a Business (Amendments to IFRS 3)
--------------------------------------------------------------------
Definition of Material (Amendments to IAS 1 and IAS 8)
--------------------------------------------------------------------
Amendments to IFRS 9, IAS 39 and IFRS 17: Interest Benchmark reform
--------------------------------------------------------------------
(2) New Standards and Interpretations not yet effective
There are a number of new standards, amendments to standard, and
interpretations which have been issued by the IASB that are
effective in future periods that the group has decided not to adopt
early.
The following amendments are effective for the period beginning
1 January 2022:
Effective date New standards or amendments
1 January 2022 Onerous contracts - Cost of Fulfilling a Contract (Amendments to IAS 37)
-------------------------------------------------------------------------------------------
References to Conceptual Framework (Amendments to IFRS 3)
-------------------------------------------------------------------------------------------
Property, Plant and Equipment: Proceeds before Intended Use (amendments to IAS16
-------------------------------------------------------------------------------------------
Annual Improvements to IFRS Standards 2018-2020 (Amendments to IFRS 1, IFRS 9, IFRS 16 and
IAS 41)
-------------------------------------------------------------------------------------------
1 January 2023 IFRS 17 Insurance Contracts
-------------------------------------------------------------------------------------------
The Group does not expect any other standard issued by the IASB,
but not yet endorsed by the UK Endorsement Board ("UKEB"), to have
a material impact on the group.
(3) Revenue
Revenue recorded in the Statement of Comprehensive Loss consists
of the following:
For the year ended 31 December: 2021 2020
$'000 $'000
------ ------
Service revenue (and transferred over
time) 1,544 480
Total revenue in Consolidated Statement
of Loss 1,544 480
====== ======
Contract Balances
Contract liabilities represent the Group's obligation to
transfer products or services to a customer for which consideration
has been received. When applicable, contract assets and liabilities
are reported on a net basis at the contract level, depending on the
contracts position at the end of each reporting period. Contract
liabilities are included within deferred revenue on the
Consolidated Statement of Financial Position. At the point of
inception all contracts were expected to be completed within 12
months and therefore, no discounting of the contract liabilities
has been accounted for.
As of 31 December: 2021 2020
$'000 $'000
-------- --------
Deferred revenue, current (4,948) (3,697)
======== ========
(4) Operating Segments
Basis for Segmentation
For management purposes, the Group's principal operations are
currently organised in three types of activities:
(i) Early stage companies - subsidiary businesses that are in
the early stage of their lifecycle characterised by incubation,
research and development activities;
(ii) Later stage companies - subsidiary businesses that have
substantially advanced with or completed their research and
development activities, are closer in their lifecycle to
commercialisation, and/or have a potential of realising material
return on investment through a future liquidity event;
(iii) Minority holdings companies - reflects the activity
related to portfolio companies other than consolidated subsidiary
businesses where the Group has made a minority investment and does
not control or exercise joint control over the financial and
operating policies of those entities. This segment will only
include the results of entities which were deconsolidated during
the accounting period. As of 31 December 2021, this operating
segment includes OcuTerra Therapeutics, Inc. profit and loss for
the period up to deconsolidation on 27 April 2021 as well as Spark
Insights, Inc. profit and loss for the period up to its disposal on
29 October 2021.
Minority holdings: During the period there was one
deconsolidation and one disposal. The results of the two companies
up to the point of deconsolidation and disposal, respectively, is
included in the Minority Holdings segment below and included the
following:
-- OcuTerra Therapeutics, Inc., one of the company's
subsidiaries that was deconsolidated during the first half of 2021
as a result of financing events at the company.
-- Concirrus LTD (Spark Insights, Inc.) a company in which
Allied Minds holds a minority stake. Spark was disposed of during
the second half of 2021 as a result of the sale of the subsidiary
to Concirrus.
The Group's CODM reviews internal management reports on these
segments at least quarterly in order to make decisions about
resources to be allocated to the segment and to assess its
performance.
Other operations include the management function of the head
office at the parent level of Allied Minds.
Information about Reportable Segments
The following provides detailed information of the Group's
reportable segments as of and for the years ended 31 December 2021
and 2020, respectively:
Minority Other
Later Stage Holdings Operations Consolidated
Statement of Comprehensive
Loss
Revenue 1,544 _ _ 1,544
Cost of
revenue (443) _ _ (443)
Selling, general and
administrative expenses (3,089) (1,875) (5,605) (10,569)
Research and development
expenses (2,026) (624) _ (2,650)
Other expense 520 14,398 (13,894) 1,024
Finance cost, net 15,889 (8,089) (10,588) (2,788)
Share of net loss of
associates accounted for
using the equity method _ _ (2,362) (2,362)
-------------
Loss for the period 12,395 3,810 (32,449) (16,244)
Other comprehensive loss _ _ (41) (41)
Total comprehensive loss 12,395 3,810 (32,490) (16,285)
============= =========== ============= =============
Total comprehensive loss
attributable to:
Equity holders of the
parent 12,209 4,706 (32,449) (15,534)
Non-controlling interests 186 (896) _ (710)
Total comprehensive loss 12,395 3,810 (32,449) (16,244)
============= =========== ============= =============
Statement of Financial Position
Non-current assets 820 _ 34,409 35,229
Current assets 6,262 _ 14,410 20,672
---------- --- -------- ----------
Total assets 7,082 _ 48,819 55,901
Non-current liabilities (75) _ (138) (213)
Current liabilities (12,820) _ 1,787 (11,033)
Total liabilities (12,895) _ 1,649 (11,246)
---------- --- -------- ----------
Net assets/(liabilities) (5,813) _ 50,468 44,655
========== === ======== ==========
2020
$'000
--------------------------------------------------------------------
Early Later Minority Other
Stage Stage Holdings Operations Consolidated
Statement of Comprehensive
Loss
Revenue _ 480 _ _ 480
Cost of
revenue _ (210) _ _ (210)
Selling, general and
administrative expenses (526) (2,788) _ (7,183) (10,497)
Research and development
expenses (1,420) (3,292) _ _ (4,712)
Other expense _ _ _ (31,934) (31,934)
Finance cost, net (20) (5,241) _ 3,475 (1,786)
Share of net loss of
associates accounted for
using the equity method _ _ _ (6,845) (6,845)
-----------
Loss for the period (1,966) (11,051) _ (42,487) (55,504)
Other comprehensive loss _ _ _ (116) (116)
Total comprehensive loss (1,966) (11,051) _ (42,603) (55,620)
=========== =========== ========== =========== =============
Total comprehensive loss
attributable to:
Equity holders of the
parent 58 (10,596) _ (42,487) (53,025)
Non-controlling interests (2,024) (455) _ _ (2,479)
Total comprehensive loss (1,966) (11,051) _ (42,487) (55,504)
=========== =========== ========== =========== =============
Statement of Financial
Position
Non-current
assets 320 1,288 _ 42,808 44,416
Current assets 502 7,105 _ 24,977 32,584
----------- ----------- ---------- ----------- -------------
Total assets 822 8,393 _ 67,785 77,000
Non-current
liabilities (105) (1,380) _ (761) (2,246)
Current
liabilities (3,756) (27,707) _ 14,995 (16,468)
Total liabilities (3,861) (29,087) _ 14,234 (18,714)
----------- ----------- ---------- ----------- -------------
Net assets/(liabilities) (3,039) (20,694) _ 82,019 58,286
=========== =========== ========== =========== =============
Early Stage companies comprise those that receive an array of
business support resources and services from Allied Minds in order
to successfully develop early stage technologies. In addition, all
closed or dissolved subsidiaries were presented in the Early Stage
segment up to the time at which they were all dissolved.
Later Stage companies comprise those that have graduated from
Early Stage by way of further advancements in their development as
described above. This currently includes BridgeComm Inc.
The results of the management function of the head office at the
parent level of Allied Minds are reported separately as Other
Operations. As the investment in associate is a parent activity,
the share of loss, gain on deconsolidation, remeasurement of the
investments to fair value and investment in associate are disclosed
in the Other Operations segment.
Summarised information related to the Company's operating
revenues by reporting segment for the years ended 31 December 2021
and 2020 is as follows:
2021 2020
-------------------------
Service revenue Software revenue Total Service revenue Software revenue Total
Early Stage - - - - - -
Later Stage 1,544 - 1,544 480 - 480
Minority - - - - - -
---------------- ----------------- ------ ---------------- ----------------- ------
Total revenue 1,544 - 1,544 480 - 480
---------------- ----------------- ------ ---------------- ----------------- ------
In 2021, Cost of revenue and Selling, general and administrative
expenses of Early Stage, Later Stage, Minority Holdings and Other
Operations segments included depreciation and amortisation expense
of $nil, $374,240, $9,239, and $166,626, respectively (2020:
$10,100, $460,880, $0, and $179,637, respectively).
The proportion of net assets shown above that is attributable to
non-controlling interest is disclosed further in notes 11 and
15.
Geographic Information
The Group revenues and net operating losses for the years ended
31 December 2021 and 2020 are considered to be entirely derived
from its operations within the United States and accordingly no
additional geographical disclosures are provided.
(5) Operating Expenses
The average number of persons employed by the Group (including
Directors) during the year, analysed by category, was as
follows:
For the year ended 31 December: 2021 2020
----- -----
Selling, general and administrative 16 28
Research and development 14 46
Total 30 74
===== =====
The aggregate payroll costs of these persons were as
follows:
For the year ended 31 December: 2021 2020
$'000 $'000
------ ------
Selling, general and administrative 4,959 5,873
Research and development 1,378 2,619
Total 6,337 8,492
====== ======
Total operating expenses were as follows:
For the year ended 31 December: 2021 2020
$'000 $'000
------- -------
Salaries and wages 4,669 5,903
Payroll taxes 333 158
Healthcare benefit 1,020 1,338
Other payroll cost 34 41
Share-based payments 281 1,052
Total 6,337 8,492
------- -------
Cost of revenue 443 210
Other SG&A expenses 5,610 4,624
Other R&D expenses 1,272 2,093
Total operating expenses 13,662 15,419
======= =======
2021 2020
$'000 $'000
------- -------
Auditor's remuneration
Audit of these financial statements 430 419
Audit-related assurance services 96 96
526 515
======= =======
The Group recorded an impairment charge on property and
equipment of $0.4 million (2020: $ nil million).
See note 6 for further disclosures related to share-based
payments and note 22 for management's remuneration disclosures.
(6) Share-Based Payments
UK Long Term Incentive Plan
Under the UK Long Term Incentive Plan ("LTIP"), awards of
Ordinary Shares may be made to employees, officers and directors,
and other individuals providing services to the Company and its
subsidiaries. Awards may be granted in the form of share options,
share appreciation rights, restricted or unrestricted share awards,
performance share awards, restricted share units, phantom-share
awards and other share-based awards. Vesting is subject to the
achievement of certain performance conditions and continued
services of the participant.
Awards have been granted under the LTIP based on the following
vesting criteria:
-- awards subject to performance conditions based on the
Company's total shareholder return ("TSR") performance or relative
total shareholder return (rTSR) performance over a defined of
time;
-- awards subject to performance conditions based on a basket of
shareholder value metrics ("SVM"). Performance is assessed on these
measures on a scorecard basis over a defined period of time;
-- awards that vest 100 per cent after a period of time subject
to continued service condition only.
On 10 June 2019, the Board determined to retire the long term
incentive plan (LTIP) scheme and therefore no future awards will be
made to executive directors, management and other employees.
Historic awards remained outstanding and eligible to vest in
accordance with their terms. A significant majority of the
outstanding awards are subject to relative total shareholder return
(TSR) performance; however, at the current share price, the
performance criteria of these awards will not be met and therefore,
no shares are expected to be issued under such awards.
No shares were issued in respect of historic awards under the
LTIP during 2021 (2020: 387,000 Ordinary shares). A summary of
stock option activity under the UK LTIP for the years ended 31
December 2021 and 2020, respectively, is shown below:
For the year ended
31 December: 2021 2020
------------------------------------- -------------------------------------
rTSR SVM Time rTSR SVM Time
------- ------------- ------------- ------- ------------- -------------
Number of shares
granted
at maximum ('000) - - - - - 387
Weighted average
fair value ($) - - - - - 0.36
Fair value measurement Monte Market Market Monte Market Market
basis Carlo value value Carlo value value
of ordinary of ordinary of ordinary of ordinary
share share share share
The share grants that vest upon the occurrence of a market
condition (i.e. the TSR performance) and service condition were
adjusted to current market price at the date of the grant to
reflect the effect of the market condition on the non-vested
shares' value. The Company used a Monte Carlo simulation analysis
utilising a Geometric Brownian Motion process with 50,000
simulations to value those shares. The model takes into account
share price volatilities, risk-free rate and other covariance of
comparable UK public companies and other market data to predict
distribution of relative share performance. This is applied to the
reward criteria to arrive at expected value of the TSR awards.
The share grants that vest only upon the occurrence of a
non-market performance condition (i.e. the SVM grants) and service
condition or upon passage of time were valued at the fair value of
the shares on the date of the grants the vesting conditions are
taken into account. The number of instruments included in the
measurement of the transaction amount is subsequently adjusted so
that, ultimately, the amount of recognised share-based expense is
based on the number of instruments that eventually vest. None of
the outstanding awards under the LTIP as of 31 December 2021 are
subject to SVM vesting.
The accounting charge does not necessarily represent the
intended value of share-based payments made to recipients, which
are determined by the Remuneration Committee according to
established criteria. The share-based payment charge for the fiscal
year ended 31 December 2021 related to the UK LTIP was $0.3 million
(2020: $0.9 million).
U.S. Stock Option/Stock Issuance Plan
The U.S. Stock Option/Stock Issuance Plan (the "U.S. Stock
Plan") was originally adopted by Allied Minds, Inc. (now Allied
Minds, LLC) in 2008. The U.S. Stock Plan provides for the grant of
share option awards, restricted share awards, and other awards to
acquire common stock of Allied Minds, Inc. (now Allied Minds, LLC).
All stock options granted to employees under this plan are equity
settled, for a ten-year term. Pursuant to the Company's IPO in
2014, Allied Minds Plc adopted and assumed the rights and
obligations of Allied Minds, Inc. (now Allied Minds, LLC) under
this plan except that the obligation to issue Common Stock is
replaced with an obligation to issue ordinary shares to satisfy
awards granted under the U.S. Stock Plan. As of 19 June 2014, the
maximum number of options reserved under the plan were issued and
outstanding and as a result of the Company's IPO in 2014, all
issued and outstanding options vested on 19 June 2014. The Company
does not intend to make any further grants under the U.S. Stock
Plan.
No new stock option grants were awarded in 2021 and 2020 under
the Allied Minds 2008 Plan. A summary of stock option activity in
the U.S. Stock Plan is presented in the following table:
For the twelve months ended: 31 December 2021 31 December 2020
-------------------------------- ------------------------------- -----------------------------
Number of Weighted average Number of Weighted average
options exercise price options exercise price
----------- ------------------ ---------- -----------------
Outstanding as of 1 January - - 230,000 $ 2.49
Exercised during the period - - - -
Forfeited during the period - - (230,000) $ 2.49
Outstanding as of period end - - - -
----------- ------------------- ---------- -----------------
Exercisable at period end - - - -
Intrinsic value of exercisable $ nil $ nil
As of 31 December 2021 no options were exercised (2020: nil)
resulting in $nil (2020: $ nil) additional share premium for the
period.
Allied Minds Phantom Plan
In 2007, Allied Minds established a cash settled plan for Allied
Minds employees, also known as its Phantom Plan. In 2012, the Board
of Directors adopted the Amended and Restated 2007 Phantom Plan.
Under the terms of the Amended and Restated Plan, upon a liquidity
event Allied Minds will allocate 10% of the value (after deduction
of the amount invested by Allied Minds and accrued interest at a
rate not exceeding 5% per annum) of the invested capital owned by
Allied Minds of each operating company to the plan account. Upon a
liquidity event, plan participants holding units will receive their
proportionate share of the plan account. The allocated shares at
all times remain the sole and exclusive property of Allied Minds
and holders of units have no rights or interests in Allied
Minds.
Allied Minds has not accrued any expense relating to the Phantom
Plan as of 31 December 2021 and 2020. Management records an expense
relating to this plan when it is probable that a subsidiary will be
sold and the amount of the payout is reasonably estimable or will
be paid out in accordance with the plan. Given the current
valuation of the investments and the thresholds required for
payments to be made, management has judged that is unlikely there
will be any future payouts in respect of this plan based on the
position at 31 December 2021.
Share-based Payment Expense
The Group recorded share-based payment charge/ credit related to
stock options of approximately $281,471 and $1,052,000 for the
years ended 31 December 2021 and 2020, respectively. There was no
income tax benefit recognised for share- based payment arrangements
for the years ended 31 December 2021 and 2020, respectively, due to
operating losses.
The following table provides the classification of the Group's
consolidated share-based payment expense/ income as reflected in
the Consolidated Statement of Loss:
For the year ended 31 December: 2021 2020
$'000 $'000
------ ------
Selling, general and administrative 270 991
Research and development 11 61
Total 281 1,052
====== ======
(7) Finance Cost, Net
The following table shows the breakdown of finance income and
cost:
For the year ended 31 December: 2021 2020
$'000 $'000
-------- --------
Interest income on:
- Bank deposits 45 292
Foreign exchange gain - (1)
Finance income 45 291
-------- ---------
Interest expense on:
- Financial liabilities
at amortised cost (250) (313)
Foreign exchange loss (5) (1)
-------- ---------
Finance cost contractual (255) (314)
Loss on fair value measurement
of subsidiary preferred
shares (2,578) (1,763)
Finance cost (2,833) (2,077)
-------- ---------
Total finance cost, net (2,788) (1,786)
======== =========
See note 16 for further disclosure related to subsidiary
preferred shares.
(8) Loss Per Share
The calculation of basic and diluted loss per share as of 31
December 2021 was based on the loss attributable to ordinary
shareholders of $15.5 million (2020: $53.0 million) and a weighted
average number of ordinary shares outstanding of 242,187,985 (2020:
241,901,871), calculated as follows:
Loss attributable to ordinary shareholders:
2021 2020
$'000 $'000
-------------------- --------------------
Basic Diluted Basic Diluted
--------- --------- --------- ---------
Loss for the year attributed to the owners of the Company (15,534) (15,534) (53,025) (53,025)
--------- --------- --------- ---------
Loss for the year attributed to the ordinary shareholders (15,534) (15,534) (53,025) (53,025)
========= ========= ========= =========
Weighted average number of ordinary shares:
2021 2020
-------------------------- ----------------------------
Basic Diluted Basic Diluted
------------ ------------ ------------- -------------
Issued ordinary shares on 1 January 242,187,985 242,187,985 241,563,123 241,563,123
Effect of RSUs issued _ _ 338,748 338,748
Effect of dilutive shares _ _ _ _
Weighted average ordinary shares 242,187,985 242,187,985 241,901,871 241,901,871
============ ============ ============= =============
Loss per share:
2021 2020
$ $
------- -------- -----------------
Basic Diluted Basic Diluted
------- -------- ------- --------
Loss per share (0.06) (0.06) (0.22) (0.22)
======= ======== ======= ========
(9) Property and Equipment
Information regarding the cost and accumulated depreciation of
property and equipment, net, consists of the following:
Cost
Machinery Furniture Computers
and and Leasehold and Under
in $'000 Equipment Fixtures Improvements Electronics Construction Total
---------------------- ---------- ---------- ------------- ------------ ------------- ----------
Balance as of 31
December 2019 1,049 71 871 355 208 554
Additions 64 - - 353 147 564
Transfers (454) - - - 454 0
---------- ---------- ------------- ------------ ------------- ----------
Balance as of 31
December 2020 659 71 871 708 809 3,118
Additions 309 - - 15 - 324
Disposals (347) - - - (139) (486)
Impairment - - - - (458) (458)
Deconsolidation of
subsidiaries - - - (34) - (34)
---------- ---------- ------------- ------------ ------------- ----------
Balance as of 31
December 2021 621 71 871 689 212 2,464
========== ========== ============= ============ ============= ==========
Accumulated
Depreciation
and Impairment loss
Machinery Furniture Computers
and and Leasehold and Under
in $'000 Equipment Fixtures Improvements Electronics Construction Total
---------------------- ---------- ---------- ------------- ------------ ------------- ----------
Balance as of 31
December 2019 (300) (3) (493) (273) _ (1,069)
Depreciation (175) (14) (143) (121) _ (453)
Impairment loss _ _ _ _ _ _
Disposals _ _ _ _ _ _
---------- ---------- ------------- ------------ ------------- ----------
Balance as of 31
December 2020 (475) (17) (636) (394) - (1,522)
Depreciation (221) (14) (143) (144) (523)
Disposals 347 - - - - 347
Deconsolidation of
subsidiaries - - - 21 - 21
---------- ---------- ------------- ------------ ------------- ----------
Balance as of 31
December 2021 (349) (31) (779) (518) - (1,677)
========== ========== ============= ============ ============= ==========
Property and
equipment, net
Machinery Furniture Computers
and and Leasehold and Under
in $'000 Equipment Fixtures Improvements Electronics Construction Total
------------------ ---------- ---------- ------------- ------------ ------------- ----------
Balance as of 31
December 2020 184 54 235 314 809 1,596
Balance as of 31
December 2021 272 40 92 171 212 787
Impairment of property and equipment of $0.5 million and $ nil
for the years ended 31 December 2021 and 2020, respectively, is
mainly attributed to the closing of subsidiary companies, which
resulted in the associated assets being impaired. Impairment of
property and equipment is included in selling, general and
administrative expenses in the consolidated statement of
comprehensive income.
Property and equipment under constructions represents assets
that are in the process of being built and not placed in service as
of the reporting date.
(10) Intangible Assets
Information regarding the cost and accumulated amortisation of
intangible assets is as follows:
Cost
in $'000 Software Total
---------------------------------- --- --- --------- ------
Balance as of 31 December 2019 926 926
Additions - Acquired separately - -
Disposals - -
------------- ------
Balance as of 31 December 2020 926 926
Additions - Acquired separately - -
Disposals - -
Balance as of 31 December 2021 926 926
============= ======
Accumulated amortisation
and Impairment loss
in $'000 Software Total
---------------------------------- --- --- --------- ------
lance as of 31 December 2019 (729) (729)
Amortisation (197) (197)
---------
Balance as of 31 December 2020 (926) (926)
Amortisation - -
Impairment loss - -
Balance as of 31 December 2021 (926) (926)
============= ======
Intangible assets, net
in $'000 Software Total
---------------------------------- --- --- --------- ------
Balance as of 31 December 2020 - -
Balance as of 31 December 2021 - -
Amortisation expense is included in selling, general and
administrative expenses in the consolidated statement of
comprehensive loss. Amortisation expense, recorded using the
straight-line method, was approximately $nil and $197,000 for the
years ended 31 December 2021 and 2020, respectively. This is mainly
attributed to software assets being fully amortized.
Impairment of intangible assets was $nil for the years ended 31
December 2021 and 2020. Impairment expense is included in selling,
general and administrative expenses in the Consolidated Statement
of Comprehensive Loss.
At each reporting period, management considers qualitative and
quantitative factors that define the future prospects of the
respective investment and assesses whether it supports the value of
the underlying intangible.
(11) Investments
Group Subsidiaries, associates and investments
As of 31 December 2021, Allied Minds has six portfolio
companies, including subsidiaries, associates and investments and
two holding companies. As at the 31 December 2021 the investments
in each of the companies and the accounting treatment is summarized
below:
Portfolio company Financial instruments Accounting treatment
held of financial instruments
Allied Minds LLC Ordinary shares Consolidated by the group
in line with IFRS 10 and
following management assessment
of significant control.
Allied Minds Securities Ordinary shares Consolidated by the group
Corp. in line with IFRS 10 and
following management assessment
of significant control.
BridgeComm, Inc. Ordinary share capital Consolidated by the group
and preferred shares in line with IFRS 10 and
following management assessment
of significant control.
Preferred shares are eliminated
on consolidation between
group companies, preferred
shares held by third parties
are fair valued through
profit and loss under
IFRS 9.
Concirrus, LTD (Spark Preferred shares The Group has a minority
Insights, Inc.) stake in the investment
and does not have significant
influence over the company.
The investment in preferred
shares is accounted for
at fair value through
the profit and loss under
IFRS 9.
OcuTerra Therapeutics, Ordinary share capital The Group has consolidated
Inc. and preferred shares the company up to the
point it lost control
in OcuTerra due to its
latest financing event
and was no longer a majority
owner. As a result, the
company was deconsolidated
and it retained a minority
stake in the investment.
As of the year end, the
Group does not have significant
influence over the company.
Therefore, the investment
in ordinary shares is
accounted for at fair
value through the profit
and loss under IFRS 9.
Preferred share holdings
are accounted for at fair
value through profit and
loss as investments held
by the Group under IFRS
9.
Federated Wireless, Ordinary share capital The ordinary share capital
Inc. and preferred shares ownership means that the
group has significant
influence but not control
over the entity. Therefore,
the investment in ordinary
shares is accounted for
by the equity method of
accounting under IAS 28.
Preferred share holdings
are accounted for at fair
value through profit and
loss as investments held
by the Group under IFRS
9.
Orbital sidekick, Preferred shares No ordinary shares are
Inc. owned by Allied Minds
and the directors have
judged, at the year end,
that the group does not
have significant influence
over the entity through
its preferred share holding.
Preferred share holdings
are accounted for at fair
value through profit and
loss as investments held
by the Group under IFRS
9.
TouchBistro, Inc. Ordinary shares The group has a minority
stake in the investment
and does not have significant
influence over the company.
Therefore, the investment
in ordinary shares is
accounted for at fair
value through the profit
and loss under IFRS 9.
The following outlines the formation of each subsidiary and
evolution of Allied Minds' ownership interest over the two year
period ended 31 December 2021:
Issued and Outstanding
Ownership percentage
at 31 December
Inception (1)
Location
Date (2) 2021 2020
Active subsidiaries
Holding companies
Boston,
Allied Minds, LLC 19/06/14 MA 100.00% 100.00%
Allied Minds Securities Boston,
Corp. 21/12/15 MA 100.00% 100.00%
Later stage company
BridgeComm, Inc. (3 Denver,
() 09/02/15 CO 81.15% 81.15%
Number of active subsidiaries
at 31 December: 3 3
Associates
Federated Wireless, Arlington,
Inc. (3 () 08/08/12 VA 42.72% 43.11%
Fremont,
Spin Memory, Inc. 03/12/07 CA N/A 43.01%
Other investments
Boston,
TouchBistro, Inc (4) 08/05/20 MA 1.40% 1.52%
Orbital Sidekick, San Francisco,
Inc. (3) 02/08/16 CA 26.29% 33.23%
OcuTerra Therapeutics, Cambridge,
Inc. (3)(4) 14/12/10 MA 17.06% 62.67%
Concirrus, LTD. (Spark London,
Insights, Inc.) (3) 10/29/21 UK 0.98% 70.59%
Notes:
(1) Represents ownership percentage held by Allied Minds Plc
based on the equity interest owned in ordinary shares plus
potential equity interest owned in convertible preference shares.
The current percentage ownership of each company ordinary share
capital is as follows: Allied Minds LLC 100%, Allied Minds
Securities Corp. 100%, BridgeComm, Inc. 98.47%, OcuTerra
Therapeutics, Inc. 75.26%, Federated Wireless 91.71%, TouchBistro
1.40%, Orbital Sidekick 0%;
(2) Allied Minds LLC, BridgeComm, Inc., OcuTerra Therapeutics,
Inc., Federated Wireless, Inc. and Federated Wireless Government
Solutions, Inc. have a registered office address at CT Corporation
System, Corporation Trust Center, and 1209 Orange Street,
Wilmington, DE 19801, United States. Allied Minds Securities Corp.
has a registered office address at CT Corporation System, 155
Federal Street, Suite 700, Boston, MA 02110, United States. TableUp
Inc. have a registered office address at 1209 Orange Street,
Wilmington, DE 19801. Orbital Sidekick Inc. has a registered office
at Corporation Service Company, 251 Little Falls Drive, Wilmington,
DE 19808. Concirrus, LTD. has a registred office address at New
City Court, 20 St. Thomas Street, London SE1 9RS.
(3) The preferred shares that Allied Minds has in these
companies are accounted for under IFRS 9.
(4) The common shares that Allied Minds has in these companies
are accounted for under IFRS 9.
The following tables summarise the financial information related
to the Group's subsidiaries with material non-controlling
interests, aggregated for interests in similar entities, and before
intra-group eliminations.
As of and for the year ended 31 December:
2021
$'000
Early Stage Later Stage Minority
Holdings
Statement of Comprehensive
Loss
Revenue - 1,544 -
Income for the year - 12,395 3,810
Other comprehensive income - - -
Total comprehensive income - 12,395 3,810
Comprehensive (loss)/ income
attributed to NCI - 186 (896)
Statement of Financial Position
Non-current assets - 820 -
Current assets - 6,262 -
Total assets - 7,082 -
Non-current liabilities - (75) -
Current liabilities - (12,820) -
Total liabilities - (12,895) -
Net liabilities - (5,813) -
Carrying amount of NCI - 168 -
Statement of Cash Flows
Cash flows from operating
activities - (2,089) 13,916
Cash flows from investing - (184) -
activities
Cash flows from financing
activities - 1,387 (1,186)
- (886) 12,730
2020
$'000
Early stage Later stage Minority
holdings
Statement of Comprehensive
Loss
Revenue - 480 -
Loss for the year (1,966) (11,051) -
Other comprehensive loss - - -
Total comprehensive loss (1,966) (11,051) -
Comprehensive loss attributed
to NCI (2,024) (455) -
Statement of Financial Position
Non-current assets 320 1,288
Current assets 502 7,105 -
Total assets 822 8,393
Non-current liabilities (105) (1,380)
Current liabilities (3,756) (27,707) -
Total liabilities (3,861) (29,087) -
Net liabilities (3,039) (20,694) -
Carrying amount of NCI (3,441) 1,180
Statement of Cash Flows
Cash flows from operating
activities (1,953) (6,621) -
Cash flows from investing
activities (20) (538) -
Cash flows from financing
activities 184 4,707 -
(1,789) (2,452) -
Investment in Associates
At 31 December 2021, the Group has one associate, Federated
Wireless, which is material to the Group and is equity accounted.
During the year, the group held Spin Memory as an equity accounted
for associate. Its operations were ceased in the period as the
board made the decision to liquidate this company.
Spin Memory : : As of 31 December 2020, Allied Minds' ownership
percentage went from 42.69% to 43.01% as a result of the entity's
latest financing round in July 2020. In accordance with IAS 28,
once the share of losses of an associate equals or exceeds its
"interest in the associate", the investor discontinues recognising
its share of further losses. Once Allied Minds' interest in Spin
Memory was reduced to zero no further adjustments were made to the
investment balance at 31 December 2020. As of 31 December 2021,
Allied Minds' ownership percentage remained at 43.01%.
On 23 June 2021, the Board of Spin Memory has taken the decision
to liquidate the company. Allied Minds first invested $1.5 million
in Spin Memory in November 2007 and continued to provide funding in
subsequent fundraising rounds. Allied Minds' total investment in
Spin Memory is $50.5 million. As indicated at the full year results
in March, and due to the fact the company was not able to secure
further investment from third parties, despite shareholders
providing operational and financial support, Spin Memory faced
significant liquidity issues. These were due to challenges in
securing new customers, alongside the impact of COVID-19 which
significantly delayed the required testing of its development chip
with ARM. In light of these challenges and the significant quantum
of capital committed to Spin Memory to date, the Board of Allied
Minds has concluded that it is no longer prepared to make any
further investment into Spin Memory. As of 31 December 2021, the
liquidation process is pending final environmental issues and is
expected to be completed in Q2 2022. Based on the Assignments For
The Benefit Of Creditors (ABC) proceedings Allied Minds expects to
get no payment from the process.
Ownership percentage
Location 31 December 2021 31 December 2020
Spin Memory, Inc. Fremont, CA 43.01% 43.01%
31 December 2021 31 December 2020
$'000 $'000
Group's interest in net assets of investee, _ _
beginning of period
Share of loss from continuing operations _ _
Carrying amount for equity accounted investees _ _
Unrecognised share of losses in associate (37,393) (37,393)
Total outstanding (37,393) (37,393)
Federated Wireless : As of 31 December 2020, Allied Minds'
ownership percentage went from 42.57% to 43.11% and the investment
in Federated Wireless continues to be subject to the equity method
accounting. In accordance with IAS 28, the Company's investment was
adjusted by the share of profits and losses generated by Federated
Wireless subsequent to the date of deconsolidation. As a result,
Allied Minds recorded a share of loss of $6.8 million in the
Consolidated Statements of Comprehensive Loss for the year ended 31
December 2020, that reduced the investment in Federated to a zero
balance.
As of 31 December 2021, Allied Minds' ownership percentage went
from 43.11% to 42.72% and continues to be subject to the equity
method accounting. No further adjustments were made to the
investment balance at 31 December 2021. If Federated Wireless
subsequently reports profits, Allied Minds will resume recognising
its share of those profits only after its share of the profits
equals the share of losses not recognised.
Ownership percentage
Location 31 December 2021 31 December 2020
Federated Wireless, Inc. Arlington, VA 42.72% 43.11%
31 December 2021 31 December 2020
$'000 $'000
Group's interest in net assets of
investee, beginning of period _ 6,845
Addition in the year _ _
Share of loss from continuing
operations _ (6,845)
Carrying amount for equity accounted investees _ _
Unrecognised share of losses in associate (53,169) (19,432)
Total outstanding (53,169) (19,432)
The following is summarised financial information for Federated
Wireless, based on their perspective consolidated financial
statements prepared in accordance with IFRS:
Federated Wireless
$'000
2021 2020
Revenue 11,021 2,882
Loss for the period (36,788) (28,073)
Total non-current assets 10,067 17,948
Total current assets 24,209 30,597
Total assets 34,276 48,545
Total non-current liabilities (4,516) (5,804)
Total current liabilities (86,607) (133,917)
Net assets (56,847) (91,176)
Investments at fair value
The Group's investments at fair value represent securities of
portfolio companies where Allied Minds holds preferred shares or a
minority stake in those companies. These investments are initially
measured at fair value through profit or loss and are subsequently
re-measured at fair value at each reporting date and on
derecognition.
The fair value of these investments is derived using the option
pricing model ("OPM"), the Probability-Weighted Expected Return
Method ("PWERM") or a hybrid of the two.
The key inputs into these valuation models include the equity
value of the portfolio company, the term of the instrument, risk
free rate and volatility.
The valuation methodologies utilised for determining the equity
value include market approach, income approach or cost approach or
hybrid of these approaches. Other methodologies such as asset based
and cash in are also utilised where deemed appropriate. It is noted
that in the current year none of the equity values were determined
using the income approach.
Other valuation approaches
In certain cases, the value of a portfolio company is determined
using a market instead of income- based approach.
Where there has been a third party funding round in the year
this has been used as the implied value of the portfolio company or
comparable guideline public companies or comparable transactions,
adjusted for indexation where this is deemed to be appropriate.
Whilst the Board considers the methodologies and assumptions
adopted in the valuation are supportable, reasonable and robust,
because of the inherent uncertainty of valuation, those estimated
values may differ significantly from the values that would have
been used had a ready market for the investment existed and the
differences could be material.
PWERM and OPM
The principal methods the Group applies for allocation of value
are the PWERM, the OPM as well as a hybrid of the two. These models
take assumptions such as the equity values, term of the
instruments, risk free rate and volatility to determine the fair
value of each share class.
The PWERM estimates the value of equity securities based on an
analysis of various discrete future outcomes, such as an IPO,
merger or sale, dissolution, or continued operation as a private
enterprise until a later exit date. The equity value today is based
on the probability-weighted present values of expected future
investment returns, considering each of the possible outcomes
available to the enterprise, as well as the rights of each security
class. The key judgement relates to probability weighting of the
scenarios.
The OPM treats common stock or derivatives thereof as call
options on the enterprise's value or overall equity value. The
value of a security is based on the optionality over and above the
value securities that are senior in the capital structure (e.g.
preferred stock), considering the dilutive effects of subordinate
securities. In the OPM, the exercise price is based on a comparison
with the overall equity value rather than per-share value.
Those investments are presented in the below table:
Finance
(income)/cost
from IFRS
31 December 9 fair value 31 December
2021 Disposals accounting Additions* 2020
$'000 $'000 $'000 $'000 $'000
Federated Wireless,
Inc. 14,154 _ (14,378) _ 28,532
Spin Memory,
Inc. - _ (4,821) _ 4,821
Orbital Sidekick,
Inc. 8,528 _ 564 2,500 5,464
TouchBistro,
Inc. 4,330 _ 1,559 _ 2,771
OcuTerra Therapeutics,
Inc. 6,276 _ 2,965 3,311 _
Concirrus, LTD 696 _ _ 696 _
Total investments
at fair value 33,984 _ (14,111) 6,507 41,588
* Of the total amount presented in the additions column, $1.0
million was cash used in investing activities. related to Orbital
Sidekick's latest financing. As such, on the cash flow statement,
the total cash used for purchase of investments consists of that
$1.0 million and the $4.3 million noted below related to Federated
Wireless SAFE.
Federated Wireless : The Company's investment at fair value in
Federated Wireless has changed from $28.5 million, as reported at
31 December 2020, to $14.2 million at 31 December 2021. The
decrease in investment balance primarily relates to the IFRS 9 fair
value accounting during the period.
In November 2021, Allied Minds invested $4,283,000 in the form
of SAFEs (simple agreements for equity) in Federated Wireless,
which will convert into shares of preferred stock in the company's
next equity financing round. The entire instrument is measured at
fair value through profit or loss. The SAFE is classified as a
current receivable on Allied Minds' financial position. At 31
December 2021, the entire instrument was adjusted by a fair market
gain of $0.2 million.
Spin Memory : The company's investment at fair value in Spin
Memory has changed from $4.8 million, as reported at 31 December
2020, to $nil at 31 December 2021. The change was due to the
Board's decision to liquidate the company.
Orbital Sidekick : On 6 April 2018, Allied Minds made an
investment in Orbital Sidekick, a company developing capabilities
in aerial and space-based hyperspectral imaging and analytics,
initially for the oil and gas industry. Allied Minds has
significant influence over financial and operating policies of the
investee by virtue of its large, albeit minority, stake in the
company and its representation on the entity's board of directors.
Allied Minds only held shares of preferred stock in Orbital
Sidekick. The preferred shares held by Allied Minds are not
equity-like and therefore these fall under the guidance of IFRS 9
and will be treated as a financial asset held at fair value where
all movements to the value of Allied Minds' share in the preferred
stock will be recorded through the Consolidated Statements of
Comprehensive Loss.
On 13 April 2021, Orbital Sidekick, Inc. ("OSK") completed the
closing of its $16 million Series A funding round led by Temasek,
an investment company headquartered in Singapore, with
participation from Energy Innovation Capital, Syndicate 708, and
existing investors Allied Minds and 11.2 Capital. Out of the total
financing capital raised, Allied Minds invested $2.5 million
(including the conversion of its SAFE of $1.5 million). As of 31
December 2021, Allied Minds' ownership of Orbital Sidekick's issued
share capital is 26.29% compared to 33.23% at 31 December 2020. As
of 31 December 2021, Allied Minds investment held at fair value
related to its Preferred Shares in Orbital Sidekick was valued at
$8.5 million (31 December 2020: $5.5 million).
TouchBistro : On 6 April 2018, Allied Minds made an investment
in TableUp, a software provider enabling end-to-end transparency
through the restaurant supply chain to enable more effective
inventory and operations management. On 5 August 2020, TableUp was
acquired by TouchBistro, Inc. ("TouchBistro"). The acquisition was
structured as a stock-for-stock transaction in which TouchBistro
acquired 100% of the shares of TableUp in exchange for the issuance
of TouchBistro common shares to the shareholders of TableUp. As
such, Allied Minds's investment in preferred stock, along with the
convertible note, was fully converted into common shares in
TouchBistro. A total of 2,542,662 common shares of TouchBistro was
paid to Allied Minds valued at $5.99 million at the time of the
transaction. As a result of the acquisition, Allied Minds'
ownership percentage was 1.52% at 31 December 2020. Allied Minds
does not have significant influence over the investee as it does
not hold 20% or more of the voting power of the investee as well as
it does not have any board representation. As such, the investment
does not meet the definition of an associate under IAS 28 Equity
Accounting ("IAS 28") and therefore, the common shares are
classified as an investment at fair value, under IFRS 9 Financial
Instruments ("IFRS 9"). As of 31 December 2021, Allied Minds'
ownership of TouchBistro's issued share capital is 1.40% compared
to 1.52% at 31 December 2020. At 31 December 2021, the fair value
of Allied Minds' investment in TouchBistro was measured at $4.3
million (31 December 2020: $2.8 million).
OcuTerra Therapeutics : As of April 2021, OcuTerra Therapeutics
was deconsolidated from the Group's financial statements as a
result of the first closing of its Series B Preferred Stock
financing round. On that date Allied Minds' issued and outstanding
ownership percentage dropped from 62.67% to 27.58%.
Consequently, since the Company no longer held a majority of the
voting rights in OcuTerra Therapeutics and did not hold a majority
on its board of directors, Allied Minds did not exercise effective
control over OcuTerra Therapeutics. However, even after the
transaction, Allied Minds was able to exercise significant
influence over the entity by virtue of its large, albeit minority,
stake in the company and its representation on the OcuTerra
Therapeutics's board of directors. As such, only the profits and
losses generated by OcuTerra Therapeutics through April 2021 were
included in the Group's Consolidated Statements of Comprehensive
Loss. Upon the date of deconsolidation, Allied Minds recognised an
investment in OcuTerra Therapeutics related to its common shares of
$2.4 million. Series A Preferred Stock and Series B Preferred Stock
(collectively the "OcuTerra Therapeutics Preferred Stock") held by
Allied Minds are not equity-like and therefore these fall under the
guidance of IFRS 9 and will be treated as a financial asset
held
at fair value where all movements to the value of Allied Minds'
share in the preferred stock will be recorded through the
Consolidated Statements of Comprehensive Loss. At the date of
deconsolidation these were classified as an investment at fair
value of $3.3 million. The fair value of the investment in
associate at the date of deconsolidation was based on the value
implied from the third party funding round which lead to the loss
of control. This is a market based valuation approach. As a result
of the deconsolidation, Allied Minds recorded an unrealised gain of
$14.2 million in the Consolidated Statements of Comprehensive Loss.
The gain was calculated by taking the difference between the fair
value of the interest retained in the former subsidiary at the date
control is lost less the carrying amount of net assets adjusted for
the non-controlling interests of the former subsidiary.
On 21 June 2021, OcuTerra completed the third closing of the
same Series B financing and as a result, Allied Minds' ownership
dropped to 18.98% of the issued and outstanding shares. In
addition, Allied Minds has only 1 out 7 Board of Directors
representation and therefore it is limited in its participation in
operating and capital. Based on these factors management have
judged that Allied Minds cannot alone impact the policy making
processes of the company and there are no other material
transaction between the investor and investee. It has therefore
been determined, Allied Minds no longer has significant influence
over the investee and the investment does not meet the definition
of an associate under IAS 28 at this date. As such, Allied Minds'
share of common stock is accounted as an investment at fair value
in accordance with IFRS 9 for the period beyond 21 June 2021.
Allied Minds' investment in common shares was adjusted by the
share of loss of $2.4 million generated by OcuTerra Therapeutics
for the period 27 April through 21 June 2021. This reduced the
investment in OcuTerra to a zero balance. At 21 June 2021, the
investment in OcuTerra's common shares was accounted as an
investment at fair value in accordance with IFRS 9. The investment
in OcuTerra's common shares was subsequently measured at $2.6
million from $nil at 21 June 2021. This resulted in a gain through
profit and loss in relation to the fair value of this amount.
Allied Minds recognised $2.4 million as its share of loss from
OcuTerra Therapeutics through the Consolidated Statements of
Comprehensive Loss as follows:
Ownership percentage
31 December
Location 31 December 2021 2020
OcuTerra
Therapeutics, Inc. Cambridge, MA 17.06% 62.67%
31 December
31 December 2021 2020
$'000 $'000
Group's interest in
net assets of
investee,
beginning of
period _ _
Addition in the
year 2,362 _
Share of loss from
continuing
operations (2,362) _
Carrying amount for equity accounted
investees _ _
Unrecognised share of losses in
associate (1,406) _
Total outstanding (1,406) _
Spark Insights : On 29 October 2021, Allied Minds Plc has
disposed of its portfolio company, Spark Insights, Inc. to
Concirrus, a private UK-based insurance technology company. The
acquisition was structured as a stock-for-stock transaction in
which Concirrus acquired 100% of the shares of Spark in exchange
for the issuance of Concirrus' Series A1 preferred shares. As such,
Allied Minds's investment in preferred stock, along with the
promissory notes, was fully converted into preferred shares in
Concirrus. A total of 61,252 Series A1 preferred shares of
Concirrus was paid to Allied Minds, valued at $700,000. As at 29
October 2021, Allied Minds' issued and outstanding ownership of
Spark Insights was 70.44% and fully-diluted ownership was 60.00%.
As a result of the acquisition, Allied Minds' ownership percentage
in Concirrus is 0.98%. Allied Minds has not retained any board
representation as it waived that with the disposal of Spark
Insights. As such, the company does not exercise effective control
over Spark and as a result was deconsolidated from the Group's
financial statements.
Allocation Model Inputs
Allied Minds holds shares of preferred stock in Federated
Wireless and Orbital sidekick and has significant influence over
financial and operating policies of the investee by virtue of its
stake in the companies and representation on the entity's board of
directors. Allied Minds holds a minority interest in the ordinary
share capital of TouchBistro and a minority interest in the
preferred share of Concirrus, where significant influence is not
held. It also hold a minority interest in the ordinary share
capital and preferred stock of OcuTerra Therapeutics. The preferred
shares and ordinary share capital in the investments noted above
fall under the guidance of IFRS 9 and will be treated as a
financial asset held at fair value and all movements to the value
of Allied Minds' share of these assets will be recorded through the
Consolidated Statements of Comprehensive Income/(Loss). The
following presents the quantitative information about the
significant unobservable inputs used in the fair value measurement
of the Group's financial assets:
As of 31 December: 2021 2020
Volatility 51.8%-81.2% 38.8%-73.5%
Time to Liquidity (years) 0.75 - 2.75 1.50 - 3.27
Risk-Free Rate 0.29% - 0.89% 0.10% - 0.2%
IPO/M&A/Sale Probability 0%/ 100%/ n/a 0%/ 100%/ n/a
Sensitivity Analysis
The following summarises the sensitivity from the assumptions
made by the Company in respect to the unobservable inputs used in
the fair value measurement of the Group's financial assets. The
sensitivities provided reflect reasonably possible changes to the
key assumptions:
As of 31 December: 2021 2020
$'000 $'000
Input Sensitivity Financial assets increase/(decrease)
range
Enterprise Value -2% (780) (451)
+2% 677 613
Volatility -10% 171 602
+10% (79) (290)
Time to Liquidity -6 months 534 445
+6 months (1,756) (198)
Risk-Free Rate
(1) -0.23%/-0.09% 809 445
0.18% /0.02% (465) (198)
(1) Risk-free rate is a function of the time to liquidity input
assumption.
(12) Cash and Cash Equivalents
As of 31 December: 2021 2020
$'000 $'000
Bank balances 9,710 24,489
Total cash and cash equivalents 9,710 24,489
(13) Trade and Other Receivables
As of 31 December: 2021 2020
$'000 $'000
Trade receivables 434 394
Prepayments and other current assets 5,478 5,422
Total trade and other receivables 5,912 5,816
(14) Equity
ALM's Board of Directors (the "Board") approved a new programme
to buy back up to $3.0 million of the Group's shares ("Buyback
Programme") during 2021. Share purchases took place in open market
transactions and were made from time to time depending on market
conditions, share price, trading volume and other factors. The
Buyback Programme ran from the date of the announcement to 6
October 2021. The Buyback Programme was in accordance with Allied
Minds' general authority to purchase a maximum of 24,218,799
Ordinary Shares, granted by its shareholders at the Annual General
Meeting held on 12 May 2021 and the purpose was to reduce share
capital. Shares purchased under the Buyback Programme will be
cancelled. As of 31 December 2021, the company has repurchased
2,537,712 of its own shares for a total value of $737,678.
During 2021 and 2020, there were no options exercised under the
U.S. Stock Plan. Additionally, no shares (2020: 624,862 shares)
were issued to existing and former employees of the Group during
the year as result of vesting of RSUs under the LTIP.
As of 31 December 2021, 11,551,496 ordinary shares were reserved
under the U.S. Stock Plan and 24,781,174 were reserved under the
LTIP, see note 6 for further discussion of the share-based payment
plans.
The table below explains the composition of equity:
As of 31 December: 2021 2020
$'000 $'000
Equity
Share capital, $0.01 par value,
issued and fully paid 3,767 3,767
242,187,985 and 242,187,985,
respectively
Treasury shares (738) _
Translation reserve 1,302 1,343
Accumulated profit 40,156 55,440
Equity attributable to owners
of the Company 44,487 60,550
Non-controlling interests 168 (2,264)
Total equity 44,655 58,286
Holders of Ordinary Shares are entitled to vote, on all matters
submitted to shareholders for a vote. Each Ordinary Share is
entitled to one vote. Each ordinary share is entitled to receive
dividends when and if declared by the Company's Board of Directors.
The Company has not declared any dividends prior to 2020. In
February 2020, Allied Minds made a special cash dividend payment to
shareholders of $39.7 million as a result of the sale of Allied
Minds' share in HawkEye in the second half of 2019.
Translation reserve comprises all foreign exchange differences
arising from the translation of the financial statements of foreign
operations.
(15) Changes in Non-Controlling Interest ("NCI")
The following summarises the changes in the non-controlling
ownership interest in subsidiaries by reportable segment,
calculated on the basis of percentage ownership of non-controlling
interest in voting stock on an as converted basis, excluding
liability classified preferred shares:
Early Stage Later Stage Consolidated
$'000 $'000 $'000
Non-controlling interest as of 31 December 2019 (1,418) 1,533 115
Share of comprehensive loss (2,024) (455) (2,479)
Effect of change in Company's ownership interest - (18) (18)
Equity-settled share based payments 1 117 118
Non-controlling interest as of 31 December 2020 (3,441) 1,177 (2,264)
Share of comprehensive loss 2,714 (3,424) (710)
Effect of change in Company's ownership interest (58) (38) (96)
Equity-settled share based payments (1) 32 31
Deconsolidation of subsidiaries 786 2,421 3,207
Non-controlling interest as of 31 December 2021 - 168 168
(16) Preferred Shares
Certain of the Group's subsidiaries have outstanding preferred
shares which have been classified as a subsidiary preferred shares
in current liabilities in accordance with IFRS 9 as the
subsidiaries have a contractual obligation to deliver cash or other
assets to the holders under certain future liquidity events, and/or
a requirement to deliver an uncertain number of common shares upon
conversion. The preferred shares do not contain mandatory dividend
rights. The preferred shares are convertible into common stock of
the subsidiary at the option of the holder and mandatorily
convertible into common stock of the subsidiary upon a qualified
public offering at or above certain value and gross proceeds
specified in the agreements or upon the vote of the holders of a
majority of the subsidiary preferred shares. Under certain
scenarios the number of common stock shares receivable on
conversion will change. The Group has elected not to bifurcate the
variable conversion feature as a derivative liability, but account
for the entire instrument at fair value through the income
statement.
The preferred shares are entitled to a vote with holders of
common stock on an as converted basis. The holders of the preferred
shares are entitled to a liquidation preference amount in the event
of a liquidation or a deemed liquidation event of the respective
subsidiary. The Group recognises the subsidiary preferred shares
balance upon the receipt of cash financing, and records the change
in its fair value for the respective reporting period through
profit and loss. Preferred shares are not allocated shares of the
subsidiary losses.
As of April 2021, OcuTerra Therapeutics was deconsolidated from
the Group's financial statements as a result of the first closing
of its Series B Preferred Stock financing round and Allied Minds'
issued and outstanding ownership percentage dropped from 62.67% to
27.58%. On that date, OcuTerra has issued $14.1 million in Series B
Preferred Shares to its third party investors. In addition, as a
result of the round OcuTerra's Series A Preferred Shares and
Special Stock went up in value by $7.7 million.
The following summarises the subsidiary preferred shares
balance:
Fair value gain or loss under
As of 31 December: 2021 IFRS 9 Disposals Additions 2020
$'000 $'000 $'000 $'000 $'000
BridgeComm 1,255 (5,242) _ _ 6,497
OcuTerra Therapeutics _ 7,704 (21,841) 14,137 _
Total subsidiary preferred shares 1,255 2,462 (21,841) 14,137 6,497
The redemption is conditional on occurrence of uncertain future
events beyond the control of the Group. The amount that would be
payable in case of such events is as follows:
2021 2020
As of 31 December: $'000 $'000
BridgeComm 1,260 6,500
Total liquidation preference 1,260 6,500
The fair value is derived using the option pricing model
("OPM"), the Probability-Weighted Expected Return Method ("PWERM")
or a hybrid of the two.
The key inputs into these valuation models include the equity
value of the subsidiary, the term of the instrument, risk free rate
and volatility.
The valuation methodologies utilised for determining the equity
value include the market approach, income approach or cost approach
or hybrid of these approaches. Other methodologies such as asset
based are also utilised where deemed appropriate. It is noted that
in the current year none of the equity values were determined using
the income approach.
Where there has been a third party funding round in the year
this has been used as the implied value of the portfolio company or
comparable guideline public companies or comparable transactions,
adjusted for indexation where this is deemed to be appropriate.
Whilst the Board considers the methodologies and assumptions
adopted in the valuation are supportable, reasonable and robust,
because of the inherent uncertainty of valuation, those estimated
values may differ significantly from the values that would have
been used had a ready market for the investment existed and the
differences could be significant.
PWERM and OPM
The principal methods the Group applies for allocation of value
are the PWERM, the OPM as well as a hybrid of the two. These models
take assumptions such as the equity values, term of the
instruments, risk free rate and volatility to determine the fair
value of each share class.
The PWERM estimates the value of equity securities based on an
analysis of various discrete future outcomes, such as an IPO,
merger or sale, dissolution, or continued operation as a private
enterprise until a later exit date. The equity value today is based
on the probability-weighted present values of expected future
investment returns, considering each of the possible outcomes
available to the enterprise, as well as the rights of each security
class. The key judgement relates to probability weighting of the
scenarios.
The OPM treats common stock or derivatives thereof as call
options on the enterprise's value or overall equity value. The
value of a security is based on the optionality over and above the
value securities that are senior in the capital structure (e.g.
preferred stock), considering the dilutive effects of subordinate
securities. In the OPM, the exercise price is based on a comparison
with the overall equity value rather than per-share value.
Allocation Model Inputs
The following presents the quantitative information about the
significant unobservable inputs used in the fair value measurement
of the Group's subsidiary preferred shares liability:
As of 31 December: 2021 2020
Volatility 77.7% 53.6%
Time to Liquidity (years) 2.00 2.00
Risk-Free Rate 0.73% 0.10%
Probability M&A n/a 100%
Sensitivity Analysis
The following summarises the sensitivity from the assumptions
made by the Company in respect to the unobservable inputs used in
the fair value measurement of the Group's subsidiary preferred
shares liability. Option Pricing Model and Probability Weighted
Expected Return Method Inputs for Investments Held at Fair Value at
31 December 2021 and 2020 respectively:
OPM Measurement Date
As of: 2021 2020
$'000 $'000
Input Sensitivity range
Enterprise Value -2% (3) (112)
+2% 35 114
Volatility -10% 35 266
+10% (3) (264)
Time to Liquidity -6 months 35 117
+6 months (3) (112)
Risk-Free Rate -0.17/-0.02 35 117
0.12/ 0.02 (3) (112)
(1) Risk-free rate is a function of the time to liquidity input
assumption.
The subsidiary preferred shares are measured at fair value
through profit/loss (FVTPL) according to IFRS 9 at initial
recognition and upon subsequent measurement. Hence, any gains and
losses on the preferred shares liability are recognised in profit
or loss, unless they relate to changes in the entity's own credit
risk for financial liability designated as at fair value through
profit or loss. The effect of changes in the entity's own credit
risk in the fair value of the financial liabilities are presented
in other comprehensive income. There were no adjustments considered
for movement in credit risk as this is not applicable within the
specific valuation frameworks utilized for the fair values of the
Group's preferred share liability. The subsidiary preferred shares
values and movement in credit risk, if applicable, are being
constantly monitored as new information becomes available. For the
year ended 31 December 2021, the change in fair value of the
subsidiary preferred shares is recorded in Finance cost, net in the
consolidated statement of comprehensive loss.
(17) Trade and Other Payables
As of 31 December: 2021 2020
$'000 $'000
Trade payables 210 319
Accrued expenses 525 1,457
Other current liabilities 326 325
Trade and other payables,
current 1,061 2,101
(18) Loans
As of 31 December: 2021 2020
$'000 $'000
Current liabilities
- Loans:
Unsecured loans 3,109 2,965
Paycheck Protection
Program (PPP) loans* _ 184
Non- Current liabilities
- Loans:
Unsecured loans _ 1,440
Total loans 3,109 4,589
*Two subsidiaires of the Group during the year, Spark Insights
and BridgeComm, have received PPP loans under the CARES Act in 2020
($0.2 million) and 2021 ($0.2 million). At 31 December 2021, the
full PPP balance decreased from $443 thousand to $nil due to PPP
loan forgiveness in current period.
The terms and conditions of outstanding loans are as
follows:
2021 2020
$'000 $'000
Currency Nominal Year of Face Carrying Face Carrying amount
As of interest maturity value amount value
31 December: rate
Unsecured
loan(1) USD 5.0% 2020-22 2,500 3,109 2,500 2,862
Unsecured
loan(2) USD 12.0% 2021-21 _ _ 100 103
Unsecured
loan(3) USD 8.0% 2020-22 _ _ 1,325 1,440
Total
interest
bearing
liabilities 2,500 3,109 3,825 4,589
BridgeComm convertible note (1)
On 16 December 2020, BridgeComm secured $1.0 million of funding
through the issuance of a convertible bridge note to Boeing
HorizonX Ventures, LLC ("Boeing"). All principal and accrued
interest shall be due and payable on 30 June 2022. In August 2021,
as a result of achieving certain development milestones under the
JDA with Boeing, BridgeComm secured the remaining $1.5 million of
convertible debt from Boeing. The $2.5 million promissory note was
issued at a 5.0% interest rate that will be compounded monthly and
computed on the basis of a year of 365 days for the actual number
of days elapsed and shall be paid on the maturity date. The loan
balance is due to amortize withinthe 12 months following the
reporting date and will be classed as a current liability. The
entire instrument is measured at fair value through profit or loss
due to the conversion feature being an embedded derivative. At 31
December 2021, the entire instrument was adjusted upward by a fair
market change of $0.1 million.
OcuTerra Therapeutics promissory note (2)
On 23 September 2020, OcuTerra Therapeutics secured $0.1 million
of funding through the issuance of a promissory note to multiple
investors at annual interest rate of 12.0% payable within one year
from the date of issuance. The note was issued at an interest rate
that will accrue on the unpaid Principal Amount at the rate of
twelve (12%) per annum computed on the basis of a 365-day year. The
note converted into preferred shares upon the closing of the Series
B funding in April 2021.
OcuTerra Therapeutics convertible note (3)
On 5 November 2020, OcuTerra Therapeutics secured $0.95 million
of funding through the issuance of a convertible bridge note to
multiple investors at annual interest rate of 8.0%. On 10 January
2021, OcuTerra Therapeutics raised an additional $0.4 million in
the second closing of its convertible note financing. The note was
issued at an interest rate that will accrue on the unpaid Principal
Amount at the rate of eight (8%) per annum, payable at the maturity
date (36 month anniversary of the closing date). All accrued
interest shall be computed on the basis of a 360-day year
consisting of twelve 30-day months, and shall be payable on the
date the outstanding principal amount shall become due and payable,
whether on the Maturity Date or by acceleration or otherwise, or
upon conversion. The entire instrument and the offsetting discount
will be measured at fair value through profit or loss as the
conversion feature fails the fixed for fixed equity classification.
The convertible note of $1.5 million converted into preferred
shares upon the closing of the Series B funding in April 2021.
(19) Leases
Office and laboratory space is rented under non-cancellable
operating leases. These lease agreements contain various clauses
for renewal at the Group's option and, in certain cases, escalation
clauses typically linked to rates of inflation.
Right of use asset
2021 2020
$000s $000s
Balance at 1 January 651 1,016
Additions 192 -
Depreciation (316) (365)
Deconsolidation (113) -
Balance at 31 December 414 651
Lease liability
2021 2020
$000s $000s
Balance at 1 January 1,830 2,854
Additions 192 -
Cash paid (1,100) (1,150)
Interest expense 71 126
Deconsolidation (120) -
Balance at 31 December 873 1,830
The following details the short term and long-term portion of
the lease liability as at 31 December 2021:
Total lease liability
$000s
Lease liability released in < 1 year 660
Lease liability released in over 1 year 213
Total Lease Liability 873
During 2019, the Group relocated its corporate headquarters and
as a result it sub-leased the office space that has been presented
as part of a right-of-use asset. As the sub-lease is for all of the
remaining useful economic life of the right-of-use asset, the
sub-lease is classified as a finance lease.
The following table sets out a maturity analysis of lease
receivables, showing the undiscounted lease payments to be received
after the reporting date. Under IAS 17, the Group did not have any
finance leases as a lessor.
In thousands of $ 31 December 2021
Less than 1 year 438
Between 1 and 5 years -
More than 5 years -
Total undiscounted lease receivable 438
Unearned finance income (24)
Net investment in the lease 414
Additions in the period relate to site leases that were entered
into by Allied Minds' consolidated subsidiaries during 2021.
Amounts were arrived at using the contractual minimal lease
payments, present valued using the applicable incremental borrowing
rate of 5.0%.
Amounts recognised in profit or loss
In thousands of $ 31 December 2021
2021 - Leases under IFRS 16
Interest on lease liabilities 71
Income from sub-leasing right-of-use assets presented in 'interest income' 45
(20) Financial Instruments and Related Disclosures
The following table shows the carrying amounts and fair values
of financial assets and financial liabilities, including their
levels in the fair value hierarchy:
As of 31 December: 2021
$'000
Carrying Fair value
Level Level Level
Amount 1 2 3 Total
Financial assets designated
as fair value through
profit or loss
Investments at fair
value 33,984 - - 33,984 33,984
Convertible note receivable 4,500 - - 4,500 4,500
Loans and receivables
Cash and cash equivalents 9,710
Trade and other receivables 5,912
Security and other
deposits 594
Total 54,700 - - 38,484 38,484
Financial liabilities
designated as fair value
through profit or loss
Convertible notes 3,109 - - 3,109 3,109
Subsidiary preferred
shares 1,255 - - 1,255 1,255
Financial liabilities
measured at amortised
cost
Trade and other payables 1,061
Lease liability 873
Total 6,298 - - 4,364 4,364
As of 31 December: 2020
$'000
Carrying Fair value
Amount Level Level Level Total
1 2 3
Financial assets designated
as fair value through
profit or loss
Investments at fair
value 41,588 - - 41,588 41,588
Convertible note receivable 1,500 - - 1,500 1,500
Loans and receivables
Cash and cash equivalents 24,489
Trade and other receivables 5,816
Security and other
deposits 1,360
Total 74,753 - - 43,088 43,088
Financial liabilities
designated as fair value
through profit or loss
Convertible notes 4,590 - - 4,590 4,590
Subsidiary preferred
shares 6,497 - - 6,497 6,497
Financial liabilities
measured at amortised
cost
Trade and other payables 2,101
Lease liability 1,830
Total 15,018 - - 11,087 11,087
Total other financials assets were as follows:
For the year ended 31 December: 2021 2020
$'000 $'000
------ ------
Deposits 44 81
Other long term assets - 500
Total 44 581
------ ------
Convertible note receivable 4,500 1,500
Other current assets 550 779
Total 5,050 2,279
5,094 2,860
The fair value of financial instruments that are not traded is
determined by using valuation techniques that maximise the use of
observable market data where it is available and rely as little as
possible on entity specific estimates. If all significant inputs
required to fair value an instrument are observable, the instrument
is included in Level 2. Where the inputs for determining the fair
value of financial instruments are not based on observable market
data, the instrument is included in Level 3. See the assumptions
for the valuation of the Convertible note receivable as disclosed
in note 11 of the financial statements. As such, for assumptions
used in the fair value measurement of the Group's convertible notes
designated as Level 3, see note 18.
For assumptions used in the fair value measurement of the
Group's subsidiary preferred shares liability designated as Level
3, see note 16. For assumptions used in the fair value measurement
of Investments at fair value designated as Level 3, see note
11.
Cash and cash equivalents, trade receivables, and trade payables
are carried at cost, which approximates fair value because of their
short-term nature.
The movement in the convertible loan note assets are presented
in the below table:
Movement
from IFRS
31 December 9 fair value 31 December
2021 Disposals accounting Additions 2020
$'000 $'000 $'000 $'000 $'000
Federated Wireless,
Inc. 4,500 _ 217 4,283 _
Orbital Sidekick,
Inc. _ (2,500) _ 1,000 1,500
Total convertible
loan note assets
at fair value 4,500 (2,500) 217 5,283 1,500
(21) Capital and Financial Risk Management
The Group's policy is to maintain a strong asset base so as to
maintain investor, creditor and market confidence and to sustain
future development of the business. Management monitors the level
of capital deployed and available for deployment in subsidiary
projects. The Board of Directors seeks to maintain a balance
between the higher returns that might be possible with higher
levels of deployed capital and the advantages and security afforded
by a sound capital position.
The Group's executive management and Board of Directors have
overall responsibility for establishment and oversight of the
Group's risk management framework. The Group is exposed to certain
risks through its normal course of operations. The Group's main
objective in using financial instruments is to promote the
commercialisation of intellectual property through the raising and
investing of funds for this purpose. The Group's policies in
calculating the nature, amount and timing of funding are determined
by planned future investment activity. Due to the nature of
activities and with the aim to maintain the investors' funds secure
and protected, the Group's policy is to hold any excess funds in
highly liquid and readily available financial instruments and
reduce the exposure to other financial risks.
The Group has exposure to the following risks arising from
financial instruments:
Credit Risk
Credit risk is the risk of financial loss to the Group if a
customer or counterparty to a financial instrument fails to meet
its contractual obligations. Financial instruments that potentially
subject the Group to concentrations of credit risk consist
principally of cash and cash equivalents, investments held at fair
value, and trade and other receivables.
The Group held following balances:
As of 31 December: 2021 2020
$'000 $'000
-------
Cash and cash equivalents 9,710 24,489
Investments held at
fair value 33,984 41,588
Trade and other receivables 5,912 5,816
49,606 71,893
=======
Risk control assesses the credit quality of the customer, taking
into account its financial position, past experience and other
factors. Individual risk limits are set based on ratings in
accordance with limits set by the Board. The utilisation of credit
limits is regularly monitored. The credit quality of financial
assets that are neither past due nor impaired can be assessed by
reference to credit ratings (if available) or to historical
information about counterparty default rates.
Group policy is to maintain its funds in highly liquid deposit
accounts with reputable financial institutions.
The Group's investments in preferred stock are accounted for at
fair value through profit or loss (FVTPL) in accordance with IFRS
9. This measurement is appropriate as these financial assets are
not held with the objective to collect contractual cash flows which
are solely payments of principal and interest (SPPI) on the
principal amount outstanding. The entity is primarily focused on
fair value information and uses that information to assess the
asset's performance and to make decisions. The subsidiary preferred
shares values and movement in credit risk are being constantly
monitored as new information becomes available.
The Group has a concentration of credit risk in respect of its
financial assets held at fair value through the profit or loss
which relate to ordinary and preferred share investments with
movements in fair value of $14.1 million. Of this balance $14.4
million in losses relates specifically to the preferred shares held
in Federate Wireless for the period. These investments are reviewed
in detail in note 11. The Group assesses the credit quality of
customers, taking into account their current financial
position.
The aging of trade receivables that were not impaired was as
follows:
As of 31 December: 2021 2020
$'000 $'000
Neither past due nor
impaired 434 135
Past due 30-90 days _ 259
Past due over 90 days _ _
Reserve for bad debt _ _
434 394
An analysis of the credit quality of trade receivables that are
neither past due nor impaired is as follows:
As of 31 December: 2021 2020
$'000 $'000
Customers with less than
three years of trading
history with the Group 434 394
434 394
Liquidity Risk
Liquidity risk is the risk that the Group will encounter
difficulty in meeting the obligations associated with its financial
liabilities that are settled by delivering cash or another
financial asset. The Group's approach to managing liquidity is to
ensure, as far as possible, that it will have sufficient liquidity
to meet its liabilities when they are due, under both normal and
stressed conditions, without incurring unacceptable losses or
risking damage to the Group's reputation.
The Group seeks to manage liquidity risk, ensuring that
sufficient liquidity is available to meet foreseeable
requirements.
The following are the remaining contractual maturities of
financial liabilities at the reporting date. The amounts are gross
and undiscounted, and include estimated interest payments and
exclude the impact of netting agreements.
As of 31 December Contractual cash flows
2021:
More
Carrying Less than 2-5 than
$'000 amount Total 1 year years 5 years
Trade and other
payables 1,061 1,061 1,061 - -
Convertible loan
notes 3,109 3,109 3,109 - -
Subsidiary preferred
shares 1,255 1,255 1,255 - -
Lease liability 873 873 660 213 -
6,298 6,298 6,085 213 -
As of 31 December Contractual cash flows
2020:
More
Carrying Less than 2-5 than
$'000 amount Total 1 year years 5 years
Trade and other
payables 2,101 2,101 2,101 - -
Convertible loan
notes 4,590 4,590 3,150 1,440 -
Subsidiary preferred
shares 6,497 6,497 6,497 - -
Lease liability 1,830 1,830 1,830 - -
15,018 15,018 13,578 1,440 -
It is not expected that the cash flows included in the maturity
analysis could occur significantly earlier, or at significantly
different amounts.
Market Risk
Market risk is the risk that changes in market prices - such as
foreign exchange rates, interest rates and equity prices - will
affect the Group's income or the value of its holdings of financial
instruments. The objective of market risk management is to manage
and control market risk exposures within acceptable parameters,
while optimising the return. The Group maintains the exposure to
market risk from such financial instruments to insignificant
levels. The Group exposure to changes in interest rates is
determined to be insignificant.
Capital Risk Management
The Group is funded by equity finance and long term borrowings.
Total capital is calculated as 'total equity' as shown in the
consolidated statement of financial position.
The Group's objectives when managing capital are to safeguard
the Group's ability to continue as a going concern in order to
provide returns for shareholders and benefits for other
stakeholders and to maintain an optimal capital structure to reduce
the cost of capital. In order to maintain or adjust the capital
structure, the Group may issue new shares or borrow new debt. The
Group has some external debt in the form of preferred shares and no
material externally imposed capital requirements. The Group's share
capital is set out in note 16.
(22) Related Parties
Transactions with Key Management Personnel
Key Management Personnel Compensation
Key management personnel compensation received comprised the
following:
For the year ended 31 December: 2021 2020
$'000 $'000
Short-term employee benefits 18 1,022
Share-based payments - 105
Total 18 1,127
Short-term employee benefits of the Group's key management
personnel include salaries and bonuses, health care and other
non-cash benefits.
Share-based payments include the value of awards granted under
the LTIP during the year. Share-based payments under the LTIP are
subject to vesting terms over future periods. See further details
of the two plans in note 6.
Key Management Personnel Transactions
Directors' remuneration for the year comprised the
following:
For the year ended 31 December: 2021 2020
$'000 $'000
Executive Directors' fees 18 1,127
Non-executive Directors' fees 345 359
Total 363 1,486
Executive management and Directors of the Company control 0.6%
of the voting shares of the Company as of 31 December 2021 (2020:
0.6 %).
The Group has not engaged in any other transactions with key
management personnel or other related parties.
(23) Taxation
Amounts recognised in profit or loss
No current income tax expense was recorded for the years ended
31 December 2021 and 2020 due to accumulated losses.
For the year ended 31 December: 2021 2020
$'000 $'000
Net income/(loss) (15,534) (53,025)
Income taxes - -
Net income/(loss) before taxes (15,534) (53,025)
Reconciliation of Effective Tax Rate
The Group is primarily subject to taxation in the US, therefore
the reconciliation of the effective tax rate has been prepared
using the US statutory tax rate. A reconciliation of the US
statutory rate to the effective tax rate is as follows:
2021 2020
% %
US federal statutory rate 21.0 21.0
Effect of state tax rate in US 5.7 5.3
Research credits 1.4 0.7
Share-based payment remeasurement (0.5) (0.4)
Permanent differences from consolidation 52.7 1.2
Other permanent differences 2.2 (0.7)
Current year income/(losses) for
which no deferred
tax asset/(liability) is recognised (82.5) (27.1)
- -
Factors that may affect future tax expense
The Group is subject to taxation in the US and UK. Additionally,
the Group is exposed to state taxation in various jurisdictions
throughout the US. Changes in corporate tax rates can change both
the current tax expense (benefit) as well as the deferred tax
expense (benefit). A UK corporation tax rate of 25% (effective 1
April 2023) was substantively enacted on 23 May 2021, increasing
the rate from 19% to 25% for future periods.
Unrecognised Deferred Tax Assets
Deferred tax assets have not been recognised in respect of the
following items, due to history of operating losses and no
convincing evidence that future taxable profit will be available
against which the Group can use the benefits therefrom, as well as
due to potential permanent restrictions under Internal Revenue Code
Section 382 rules:
As of 31 December: 2021 2020
$'000 $'000
Tax loss carry forward 74,282 79,285
Research credits 5,201 7,022
Temporary differences 24,291 15,494
Deferred tax assets 103,774 101,801
Other temporary differences - -
Deferred tax liabilities - -
Deferred tax assets, net, not recognised 103,774 101,801
Deferred tax is measured at the rates that are expected to apply
in the period when the temporary differences are expected to
reverse, based on tax rates and laws that have been enacted or
substantially enacted by the statement of financial position
date.
As of 31 December 2021 the Company had United States federal net
operating losses carry forwards ("NOLs") of approximately $277.6
million (2020: $292.7 million) available to offset future taxable
income, if any. These carryforwards start to expire in 2024 and are
subject to review and possible adjustment by the Internal Revenue
Service. The Company may be subject to limitations under Section
382 of the Internal Revenue Code as a result of changes in
ownership. The Company's preliminary analysis on the impact from
Section 382 limitations suggests that there is unlikely to be a
material restriction on NOLs. A detailed exercise is ongoing. Upon
the completion of the study, there may or may not be limitations on
the Company's ability to utilise its current NOLs against future
profits, although these are not expected to be material.
(24) Subsequent Events
On 28 March 2022, Allied Minds plc (LSE: ALM) has completed the
disposal of its residual shareholding in TouchBistro for $5.5
million CAD ($4.4 million USD) in line with its strategy of
monetising its investment portfolio. Of the sale proceeds, $5.0
million CAD has been received and $0.5 million CAD is to be held in
escrow, with an initial release date in the third quarter of 2022,
subject to any then outstanding claims.
On 2 May 2022, Federated Wireless, Inc., ("Federated"), the
industry leader in enterprise shared spectrum 5G private wireless,
completed a $72.0 million in Series D funding at a pre new-money
valuation of $230.0 million. Participants in Federated's latest
financing round include an affiliate of Cerberus Capital
Management, L.P. ("Cerberus"), a new investor, alongside existing
investors GIC (Singapore's sovereign wealth fund) and Allied
Minds.
On 8 June 2022, Allied Minds and AE Industrial HorizonX Venture
Fund I, LP (HorizonX), jointly contributed an aggregate of $0.8
million of convertible bridge financing to BridgeComm, each
contributing $0.4 million. The bridge financing will be applied to
support the business to the completion of a new financing
round.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
FR FFFFLRTISLIF
(END) Dow Jones Newswires
June 15, 2022 02:00 ET (06:00 GMT)
Allied Minds (LSE:ALM)
過去 株価チャート
から 11 2024 まで 12 2024
Allied Minds (LSE:ALM)
過去 株価チャート
から 12 2023 まで 12 2024
